date generated: 2026-06-04
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
| x | |
|---|---|
| INF2 | -4.987563 |
| MAPK1 | 4.340409 |
| ITM2B | -3.288005 |
| VPS29 | -3.186019 |
| ARRB1 | 3.172493 |
| CDHR5 | 3.055350 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 2830 |
| num_genes_in_profile | 904 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 756 |
| num_profile_genes_not_in_sets | 148 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 2830 |
| num_genesets_excluded | 2455 |
| num_genesets_included | 375 |
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Metabolism of lipids | 30 | 0.00166 | -0.3370 | 0.488 |
| Peptide hormone metabolism | 15 | 0.00394 | 0.4330 | 0.488 |
| Formation of the cornified envelope | 28 | 0.00414 | 0.3180 | 0.488 |
| Keratinization | 28 | 0.00414 | 0.3180 | 0.488 |
| Platelet Adhesion to exposed collagen | 10 | 0.00456 | -0.5200 | 0.488 |
| Syndecan interactions | 10 | 0.00535 | -0.5110 | 0.488 |
| Diseases associated with O-glycosylation of proteins | 9 | 0.00569 | -0.5340 | 0.488 |
| Non-integrin membrane-ECM interactions | 19 | 0.00649 | -0.3640 | 0.488 |
| Neutrophil degranulation | 152 | 0.00733 | 0.1380 | 0.490 |
| Mitochondrial protein degradation | 6 | 0.00918 | -0.6160 | 0.553 |
| EPHA-mediated growth cone collapse | 7 | 0.01100 | -0.5570 | 0.603 |
| Cellular responses to stimuli | 86 | 0.01230 | -0.1640 | 0.616 |
| Innate Immune System | 277 | 0.01710 | 0.0993 | 0.747 |
| Diseases of carbohydrate metabolism | 6 | 0.01850 | 0.5570 | 0.747 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 5 | 0.02000 | -0.6020 | 0.747 |
| RHOBTB GTPase Cycle | 8 | 0.02050 | -0.4750 | 0.747 |
| Signaling by Rho GTPases | 70 | 0.02450 | -0.1620 | 0.747 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 70 | 0.02450 | -0.1620 | 0.747 |
| Muscle contraction | 16 | 0.02700 | -0.3220 | 0.747 |
| EPH-Ephrin signaling | 20 | 0.02760 | -0.2880 | 0.747 |
| Scavenging by Class B Receptors | 7 | 0.02840 | -0.4800 | 0.747 |
| Lysosome Vesicle Biogenesis | 6 | 0.03010 | 0.5130 | 0.747 |
| Folding of actin by CCT/TriC | 6 | 0.03030 | -0.5120 | 0.747 |
| Association of TriC/CCT with target proteins during biosynthesis | 6 | 0.03260 | -0.5060 | 0.747 |
| Sensory processing of sound | 5 | 0.03290 | -0.5520 | 0.747 |
| Phospholipid metabolism | 5 | 0.03460 | -0.5470 | 0.747 |
| Mitochondrial biogenesis | 6 | 0.03560 | -0.4970 | 0.747 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 10 | 0.03580 | -0.3850 | 0.747 |
| MET activates PTK2 signaling | 8 | 0.03930 | -0.4230 | 0.747 |
| Signal Transduction | 187 | 0.03950 | -0.0976 | 0.747 |
| VEGFA-VEGFR2 Pathway | 10 | 0.03970 | -0.3780 | 0.747 |
| Fatty acid metabolism | 11 | 0.03980 | -0.3600 | 0.747 |
| RHOBTB2 GTPase cycle | 7 | 0.04180 | -0.4460 | 0.747 |
| Cellular responses to stress | 68 | 0.04220 | -0.1480 | 0.747 |
| Immune System | 337 | 0.04480 | 0.0797 | 0.757 |
| Cell-extracellular matrix interactions | 9 | 0.04530 | -0.3870 | 0.757 |
| EPHB-mediated forward signaling | 12 | 0.04650 | -0.3340 | 0.757 |
| Complement cascade | 91 | 0.05570 | 0.1220 | 0.876 |
| Smooth Muscle Contraction | 12 | 0.05840 | -0.3180 | 0.876 |
| Cell surface interactions at the vascular wall | 75 | 0.06590 | -0.1280 | 0.876 |
| RHO GTPase cycle | 38 | 0.06660 | -0.1760 | 0.876 |
| ECM proteoglycans | 23 | 0.06740 | -0.2230 | 0.876 |
| RHOH GTPase cycle | 8 | 0.06770 | -0.3750 | 0.876 |
| Response of endothelial cells to shear stress | 16 | 0.07070 | -0.2630 | 0.876 |
| Metabolism of Angiotensinogen to Angiotensins | 7 | 0.07230 | 0.3940 | 0.876 |
| RHO GTPases activate PAKs | 7 | 0.07560 | -0.3890 | 0.876 |
| Interaction between L1 and Ankyrins | 5 | 0.07620 | 0.4590 | 0.876 |
| Signaling by VEGF | 13 | 0.07720 | -0.2850 | 0.876 |
| Asparagine N-linked glycosylation | 41 | 0.07990 | 0.1620 | 0.876 |
| Lectin pathway of complement activation | 8 | 0.08000 | 0.3590 | 0.876 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Metabolism of lipids | 30 | 0.00166 | -0.337000 | 0.488 |
| Peptide hormone metabolism | 15 | 0.00394 | 0.433000 | 0.488 |
| Formation of the cornified envelope | 28 | 0.00414 | 0.318000 | 0.488 |
| Keratinization | 28 | 0.00414 | 0.318000 | 0.488 |
| Platelet Adhesion to exposed collagen | 10 | 0.00456 | -0.520000 | 0.488 |
| Syndecan interactions | 10 | 0.00535 | -0.511000 | 0.488 |
| Diseases associated with O-glycosylation of proteins | 9 | 0.00569 | -0.534000 | 0.488 |
| Non-integrin membrane-ECM interactions | 19 | 0.00649 | -0.364000 | 0.488 |
| Neutrophil degranulation | 152 | 0.00733 | 0.138000 | 0.490 |
| Mitochondrial protein degradation | 6 | 0.00918 | -0.616000 | 0.553 |
| EPHA-mediated growth cone collapse | 7 | 0.01100 | -0.557000 | 0.603 |
| Cellular responses to stimuli | 86 | 0.01230 | -0.164000 | 0.616 |
| Innate Immune System | 277 | 0.01710 | 0.099300 | 0.747 |
| Diseases of carbohydrate metabolism | 6 | 0.01850 | 0.557000 | 0.747 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 5 | 0.02000 | -0.602000 | 0.747 |
| RHOBTB GTPase Cycle | 8 | 0.02050 | -0.475000 | 0.747 |
| Signaling by Rho GTPases | 70 | 0.02450 | -0.162000 | 0.747 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 70 | 0.02450 | -0.162000 | 0.747 |
| Muscle contraction | 16 | 0.02700 | -0.322000 | 0.747 |
| EPH-Ephrin signaling | 20 | 0.02760 | -0.288000 | 0.747 |
| Scavenging by Class B Receptors | 7 | 0.02840 | -0.480000 | 0.747 |
| Lysosome Vesicle Biogenesis | 6 | 0.03010 | 0.513000 | 0.747 |
| Folding of actin by CCT/TriC | 6 | 0.03030 | -0.512000 | 0.747 |
| Association of TriC/CCT with target proteins during biosynthesis | 6 | 0.03260 | -0.506000 | 0.747 |
| Sensory processing of sound | 5 | 0.03290 | -0.552000 | 0.747 |
| Phospholipid metabolism | 5 | 0.03460 | -0.547000 | 0.747 |
| Mitochondrial biogenesis | 6 | 0.03560 | -0.497000 | 0.747 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 10 | 0.03580 | -0.385000 | 0.747 |
| MET activates PTK2 signaling | 8 | 0.03930 | -0.423000 | 0.747 |
| Signal Transduction | 187 | 0.03950 | -0.097600 | 0.747 |
| VEGFA-VEGFR2 Pathway | 10 | 0.03970 | -0.378000 | 0.747 |
| Fatty acid metabolism | 11 | 0.03980 | -0.360000 | 0.747 |
| RHOBTB2 GTPase cycle | 7 | 0.04180 | -0.446000 | 0.747 |
| Cellular responses to stress | 68 | 0.04220 | -0.148000 | 0.747 |
| Immune System | 337 | 0.04480 | 0.079700 | 0.757 |
| Cell-extracellular matrix interactions | 9 | 0.04530 | -0.387000 | 0.757 |
| EPHB-mediated forward signaling | 12 | 0.04650 | -0.334000 | 0.757 |
| Complement cascade | 91 | 0.05570 | 0.122000 | 0.876 |
| Smooth Muscle Contraction | 12 | 0.05840 | -0.318000 | 0.876 |
| Cell surface interactions at the vascular wall | 75 | 0.06590 | -0.128000 | 0.876 |
| RHO GTPase cycle | 38 | 0.06660 | -0.176000 | 0.876 |
| ECM proteoglycans | 23 | 0.06740 | -0.223000 | 0.876 |
| RHOH GTPase cycle | 8 | 0.06770 | -0.375000 | 0.876 |
| Response of endothelial cells to shear stress | 16 | 0.07070 | -0.263000 | 0.876 |
| Metabolism of Angiotensinogen to Angiotensins | 7 | 0.07230 | 0.394000 | 0.876 |
| RHO GTPases activate PAKs | 7 | 0.07560 | -0.389000 | 0.876 |
| Interaction between L1 and Ankyrins | 5 | 0.07620 | 0.459000 | 0.876 |
| Signaling by VEGF | 13 | 0.07720 | -0.285000 | 0.876 |
| Asparagine N-linked glycosylation | 41 | 0.07990 | 0.162000 | 0.876 |
| Lectin pathway of complement activation | 8 | 0.08000 | 0.359000 | 0.876 |
| Apoptotic cleavage of cell adhesion proteins | 5 | 0.08020 | 0.453000 | 0.876 |
| Infectious disease | 171 | 0.08140 | -0.085500 | 0.876 |
| Disease | 248 | 0.08280 | -0.074700 | 0.876 |
| Organelle biogenesis and maintenance | 24 | 0.08400 | -0.207000 | 0.876 |
| Generic Transcription Pathway | 50 | 0.08460 | -0.145000 | 0.876 |
| RNA Polymerase II Transcription | 50 | 0.08460 | -0.145000 | 0.876 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | 8 | 0.08480 | -0.354000 | 0.876 |
| Signaling by NOTCH3 | 5 | 0.08600 | -0.445000 | 0.876 |
| Formation of Fibrin Clot (Clotting Cascade) | 32 | 0.08720 | 0.178000 | 0.876 |
| HSF1 activation | 7 | 0.08730 | -0.375000 | 0.876 |
| Cell junction organization | 46 | 0.08910 | -0.149000 | 0.880 |
| Signaling by NOTCH4 | 16 | 0.09450 | -0.244000 | 0.913 |
| Metabolism of steroids | 5 | 0.09690 | -0.430000 | 0.913 |
| GP1b-IX-V activation signalling | 8 | 0.10500 | -0.333000 | 0.913 |
| Glutathione conjugation | 5 | 0.10700 | -0.417000 | 0.913 |
| Translation of Structural Proteins 9694635 | 6 | 0.10800 | 0.380000 | 0.913 |
| MyD88 cascade initiated on plasma membrane | 5 | 0.11600 | 0.407000 | 0.913 |
| Toll Like Receptor 10 (TLR10) Cascade | 5 | 0.11600 | 0.407000 | 0.913 |
| Toll Like Receptor 3 (TLR3) Cascade | 5 | 0.11600 | 0.407000 | 0.913 |
| Toll Like Receptor 5 (TLR5) Cascade | 5 | 0.11600 | 0.407000 | 0.913 |
| O-linked glycosylation | 9 | 0.11600 | -0.304000 | 0.913 |
| MyD88 dependent cascade initiated on endosome | 6 | 0.11700 | 0.371000 | 0.913 |
| MyD88-independent TLR4 cascade | 6 | 0.11700 | 0.371000 | 0.913 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 6 | 0.11700 | 0.371000 | 0.913 |
| TRIF (TICAM1)-mediated TLR4 signaling | 6 | 0.11700 | 0.371000 | 0.913 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | 6 | 0.11700 | 0.371000 | 0.913 |
| Toll Like Receptor 9 (TLR9) Cascade | 6 | 0.11700 | 0.371000 | 0.913 |
| Metal sequestration by antimicrobial proteins | 5 | 0.12000 | -0.403000 | 0.917 |
| Gene expression (Transcription) | 57 | 0.12000 | -0.123000 | 0.917 |
| Formation of the dystrophin-glycoprotein complex (DGC) | 7 | 0.12500 | -0.337000 | 0.939 |
| Glycosaminoglycan metabolism | 14 | 0.13100 | 0.235000 | 0.954 |
| Transcriptional regulation by RUNX1 | 18 | 0.13100 | -0.208000 | 0.954 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 11 | 0.13100 | -0.264000 | 0.954 |
| Intrinsic Pathway of Fibrin Clot Formation | 22 | 0.13900 | 0.185000 | 0.975 |
| TGF-beta receptor signaling activates SMADs | 9 | 0.14400 | -0.283000 | 0.975 |
| LDL remodeling | 5 | 0.14400 | -0.378000 | 0.975 |
| Plasma lipoprotein remodeling | 17 | 0.14800 | -0.205000 | 0.975 |
| Defects of platelet adhesion to exposed collagen | 6 | 0.15200 | -0.339000 | 0.975 |
| Platelet activation, signaling and aggregation | 103 | 0.15200 | -0.086700 | 0.975 |
| Platelet homeostasis | 6 | 0.15300 | -0.338000 | 0.975 |
| Semaphorin interactions | 16 | 0.16100 | -0.204000 | 0.975 |
| Sensory Perception | 20 | 0.16300 | -0.182000 | 0.975 |
| Formation of tubulin folding intermediates by CCT/TriC | 10 | 0.16400 | -0.256000 | 0.975 |
| Attenuation phase | 5 | 0.16500 | -0.360000 | 0.975 |
| HSF1-dependent transactivation | 5 | 0.16500 | -0.360000 | 0.975 |
| Cellular responses to mechanical stimuli | 18 | 0.16500 | -0.191000 | 0.975 |
| Uptake and actions of bacterial toxins | 6 | 0.17100 | -0.324000 | 0.975 |
| C-type lectin receptors (CLRs) | 17 | 0.17500 | -0.192000 | 0.975 |
| NCAM signaling for neurite out-growth | 10 | 0.17500 | 0.249000 | 0.975 |
| EPH-ephrin mediated repulsion of cells | 7 | 0.18000 | -0.294000 | 0.975 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 9 | 0.18700 | 0.256000 | 0.975 |
| Maturation of spike protein 9694548 | 5 | 0.18900 | 0.341000 | 0.975 |
| Arachidonate metabolism | 9 | 0.18900 | -0.254000 | 0.975 |
| Diseases of signal transduction by growth factor receptors and second messengers | 51 | 0.19300 | -0.108000 | 0.975 |
| MAP2K and MAPK activation | 16 | 0.19400 | 0.189000 | 0.975 |
| Signaling by high-kinase activity BRAF mutants | 16 | 0.19400 | 0.189000 | 0.975 |
| Cell-Cell communication | 51 | 0.19700 | -0.107000 | 0.975 |
| Sema4D induced cell migration and growth-cone collapse | 7 | 0.20400 | -0.279000 | 0.975 |
| Defective binding of VWF variant to GPIb:IX:V | 5 | 0.20500 | -0.329000 | 0.975 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | 5 | 0.20500 | -0.329000 | 0.975 |
| Viral Infection Pathways | 122 | 0.20700 | -0.071000 | 0.975 |
| Regulation of Complement cascade | 81 | 0.21100 | 0.084200 | 0.975 |
| Transport to the Golgi and subsequent modification | 28 | 0.21100 | 0.139000 | 0.975 |
| Aerobic respiration and respiratory electron transport | 13 | 0.22100 | -0.198000 | 0.975 |
| Keratan sulfate biosynthesis | 6 | 0.22200 | 0.289000 | 0.975 |
| Ion channel transport | 5 | 0.22700 | -0.313000 | 0.975 |
| IRE1alpha activates chaperones | 6 | 0.22800 | -0.285000 | 0.975 |
| Advanced glycosylation endproduct receptor signaling | 6 | 0.22900 | 0.285000 | 0.975 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | 7 | 0.23000 | -0.263000 | 0.975 |
| Axon guidance | 71 | 0.23000 | -0.085700 | 0.975 |
| Nervous system development | 72 | 0.23100 | -0.085000 | 0.975 |
| Respiratory Syncytial Virus Infection Pathway | 9 | 0.23500 | -0.230000 | 0.975 |
| Unfolded Protein Response (UPR) | 8 | 0.23500 | -0.244000 | 0.975 |
| Class I MHC mediated antigen processing & presentation | 36 | 0.23500 | -0.117000 | 0.975 |
| Sema4D in semaphorin signaling | 8 | 0.24100 | -0.241000 | 0.975 |
| XBP1(S) activates chaperone genes | 5 | 0.24400 | -0.302000 | 0.975 |
| Signaling by ROBO receptors | 17 | 0.24500 | -0.165000 | 0.975 |
| Nuclear events mediated by NFE2L2 | 21 | 0.24500 | -0.148000 | 0.975 |
| Diseases of glycosylation | 16 | 0.24500 | -0.169000 | 0.975 |
| Translation of Structural Proteins 9683701 | 5 | 0.24600 | 0.301000 | 0.975 |
| Basigin interactions | 5 | 0.24800 | -0.299000 | 0.975 |
| Thrombin signalling through proteinase activated receptors (PARs) | 7 | 0.25200 | 0.251000 | 0.975 |
| Infection with Mycobacterium tuberculosis | 9 | 0.25600 | 0.220000 | 0.975 |
| Ficolins bind to repetitive carbohydrate structures on the target cell surface | 5 | 0.26200 | 0.291000 | 0.975 |
| Platelet degranulation | 82 | 0.26400 | -0.074800 | 0.975 |
| Response to elevated platelet cytosolic Ca2+ | 82 | 0.26400 | -0.074800 | 0.975 |
| RAB geranylgeranylation | 9 | 0.26900 | -0.214000 | 0.975 |
| trans-Golgi Network Vesicle Budding | 12 | 0.26900 | 0.186000 | 0.975 |
| Dengue Virus Genome Translation and Replication | 12 | 0.27100 | -0.185000 | 0.975 |
| Activation of Matrix Metalloproteinases | 9 | 0.27100 | 0.213000 | 0.975 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 8 | 0.27600 | -0.223000 | 0.975 |
| Formation of paraxial mesoderm | 11 | 0.27900 | -0.190000 | 0.975 |
| Somitogenesis | 11 | 0.27900 | -0.190000 | 0.975 |
| Prefoldin mediated transfer of substrate to CCT/TriC | 10 | 0.27900 | -0.199000 | 0.975 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | 12 | 0.28400 | -0.180000 | 0.975 |
| Calnexin/calreticulin cycle | 7 | 0.28400 | 0.235000 | 0.975 |
| Fcgamma receptor (FCGR) dependent phagocytosis | 64 | 0.28800 | -0.079700 | 0.975 |
| DNA Repair | 5 | 0.28800 | -0.275000 | 0.975 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 17 | 0.28900 | 0.150000 | 0.975 |
| Signaling by RAS mutants | 17 | 0.28900 | 0.150000 | 0.975 |
| Signaling by moderate kinase activity BRAF mutants | 17 | 0.28900 | 0.150000 | 0.975 |
| Signaling downstream of RAS mutants | 17 | 0.28900 | 0.150000 | 0.975 |
| Laminin interactions | 10 | 0.29000 | -0.194000 | 0.975 |
| Nucleotide salvage | 5 | 0.29100 | -0.274000 | 0.975 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | 13 | 0.29800 | -0.168000 | 0.975 |
| Hemostasis | 194 | 0.30300 | -0.048200 | 0.975 |
| FCGR3A-mediated phagocytosis | 61 | 0.30400 | -0.078800 | 0.975 |
| Leishmania phagocytosis | 61 | 0.30400 | -0.078800 | 0.975 |
| Parasite infection | 61 | 0.30400 | -0.078800 | 0.975 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 11 | 0.30600 | 0.179000 | 0.975 |
| Toll Like Receptor 2 (TLR2) Cascade | 11 | 0.30600 | 0.179000 | 0.975 |
| Toll Like Receptor TLR1:TLR2 Cascade | 11 | 0.30600 | 0.179000 | 0.975 |
| Toll Like Receptor TLR6:TLR2 Cascade | 11 | 0.30600 | 0.179000 | 0.975 |
| Chaperonin-mediated protein folding | 15 | 0.31400 | -0.152000 | 0.975 |
| Protein folding | 15 | 0.31400 | -0.152000 | 0.975 |
| Late SARS-CoV-2 Infection Events | 7 | 0.31500 | 0.221000 | 0.975 |
| Degradation of the extracellular matrix | 28 | 0.31900 | 0.111000 | 0.975 |
| Maturation of DENV proteins | 8 | 0.32000 | -0.204000 | 0.975 |
| Cell-cell junction organization | 35 | 0.32100 | -0.098900 | 0.975 |
| GPER1 signaling | 7 | 0.32200 | -0.217000 | 0.975 |
| Toll Like Receptor 4 (TLR4) Cascade | 13 | 0.32400 | 0.159000 | 0.975 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | 8 | 0.32500 | 0.202000 | 0.975 |
| Developmental Cell Lineages | 5 | 0.32600 | -0.255000 | 0.975 |
| Developmental Cell Lineages of the Exocrine Pancreas | 5 | 0.32600 | -0.255000 | 0.975 |
| Developmental Lineage of Pancreatic Ductal Cells | 5 | 0.32600 | -0.255000 | 0.975 |
| KEAP1-NFE2L2 pathway | 23 | 0.32800 | -0.119000 | 0.975 |
| Cellular response to heat stress | 12 | 0.33100 | -0.163000 | 0.975 |
| Drug ADME | 11 | 0.33200 | -0.170000 | 0.975 |
| Adaptive Immune System | 127 | 0.33200 | -0.053600 | 0.975 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 6 | 0.33400 | -0.229000 | 0.975 |
| PI3K/AKT Signaling in Cancer | 6 | 0.33400 | -0.229000 | 0.975 |
| RHO GTPase Effectors | 40 | 0.33500 | -0.090200 | 0.975 |
| Chylomicron assembly | 8 | 0.33700 | -0.197000 | 0.975 |
| Adherens junctions interactions | 34 | 0.33700 | -0.097100 | 0.975 |
| Common Pathway of Fibrin Clot Formation | 17 | 0.33700 | 0.136000 | 0.975 |
| Late endosomal microautophagy | 5 | 0.33900 | 0.248000 | 0.975 |
| Transcriptional Regulation by TP53 | 16 | 0.33900 | -0.139000 | 0.975 |
| Translation | 17 | 0.34000 | -0.135000 | 0.975 |
| Diseases associated with glycosaminoglycan metabolism | 6 | 0.34000 | 0.226000 | 0.975 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | 5 | 0.34200 | 0.246000 | 0.975 |
| Leishmania infection | 73 | 0.34700 | -0.066400 | 0.975 |
| Parasitic Infection Pathways | 73 | 0.34700 | -0.066400 | 0.975 |
| Signaling by RAF1 mutants | 16 | 0.35000 | 0.136000 | 0.975 |
| MET promotes cell motility | 10 | 0.35100 | -0.171000 | 0.975 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | 11 | 0.35300 | 0.163000 | 0.975 |
| ESR-mediated signaling | 13 | 0.35300 | -0.150000 | 0.975 |
| Metabolism of carbohydrates and carbohydrate derivatives | 42 | 0.35400 | 0.084600 | 0.975 |
| Striated Muscle Contraction | 5 | 0.35500 | -0.240000 | 0.975 |
| Metabolism | 155 | 0.36000 | -0.046700 | 0.975 |
| Collagen degradation | 10 | 0.36100 | 0.168000 | 0.975 |
| Regulation of RUNX3 expression and activity | 13 | 0.36400 | -0.147000 | 0.975 |
| ER-Phagosome pathway | 24 | 0.36500 | -0.108000 | 0.975 |
| Gamma-carboxylation of protein precursors | 7 | 0.36800 | 0.198000 | 0.975 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 7 | 0.36800 | 0.198000 | 0.975 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | 7 | 0.36800 | 0.198000 | 0.975 |
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | 7 | 0.36800 | 0.198000 | 0.975 |
| Downstream signaling events of B Cell Receptor (BCR) | 14 | 0.36900 | -0.140000 | 0.975 |
| Gastrulation | 14 | 0.37200 | -0.139000 | 0.975 |
| RHOA GTPase cycle | 12 | 0.37500 | -0.149000 | 0.975 |
| Regulation of CDH1 Function | 20 | 0.37700 | -0.115000 | 0.975 |
| Dengue Virus Infection | 33 | 0.37800 | -0.090400 | 0.975 |
| Extra-nuclear estrogen signaling | 11 | 0.37800 | -0.154000 | 0.975 |
| Anti-inflammatory response favouring Leishmania parasite infection | 58 | 0.37900 | -0.069000 | 0.975 |
| Leishmania parasite growth and survival | 58 | 0.37900 | -0.069000 | 0.975 |
| ABC transporter disorders | 13 | 0.38000 | -0.142000 | 0.975 |
| Activation of NMDA receptors and postsynaptic events | 10 | 0.38000 | 0.161000 | 0.975 |
| RAC3 GTPase cycle | 8 | 0.38200 | -0.179000 | 0.975 |
| Interleukin-12 family signaling | 16 | 0.38700 | -0.126000 | 0.975 |
| Regulation of T cell activation by CD28 family | 17 | 0.38800 | -0.122000 | 0.975 |
| Cargo trafficking to the periciliary membrane | 12 | 0.39100 | -0.144000 | 0.975 |
| Transcriptional regulation by RUNX3 | 15 | 0.39300 | -0.129000 | 0.975 |
| FCGR activation | 50 | 0.39400 | -0.071700 | 0.975 |
| Host Interactions of HIV factors | 16 | 0.39400 | -0.124000 | 0.975 |
| Signaling by WNT | 18 | 0.39900 | -0.116000 | 0.975 |
| HCMV Early Events | 8 | 0.40100 | -0.172000 | 0.975 |
| HCMV Infection | 8 | 0.40100 | -0.172000 | 0.975 |
| Protein-protein interactions at synapses | 7 | 0.40200 | -0.184000 | 0.975 |
| Signal regulatory protein family interactions | 5 | 0.40300 | 0.217000 | 0.975 |
| Golgi Associated Vesicle Biogenesis | 9 | 0.40400 | 0.162000 | 0.975 |
| Protein ubiquitination | 5 | 0.40700 | -0.215000 | 0.975 |
| Oncogenic MAPK signaling | 18 | 0.40900 | 0.114000 | 0.975 |
| Signaling by BRAF and RAF1 fusions | 18 | 0.40900 | 0.114000 | 0.975 |
| Co-inhibition by PD-1 | 13 | 0.41600 | -0.131000 | 0.975 |
| Regulation of PD-L1(CD274) Post-translational modification | 13 | 0.41600 | -0.131000 | 0.975 |
| Regulation of PD-L1(CD274) expression | 13 | 0.41600 | -0.131000 | 0.975 |
| Phase II - Conjugation of compounds | 7 | 0.41600 | -0.179000 | 0.975 |
| Cellular response to chemical stress | 37 | 0.42300 | -0.077700 | 0.975 |
| Dissolution of Fibrin Clot | 6 | 0.42500 | -0.189000 | 0.975 |
| FCGR3A-mediated IL10 synthesis | 52 | 0.42600 | -0.065700 | 0.975 |
| G-protein mediated events | 5 | 0.42800 | 0.205000 | 0.975 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 18 | 0.42800 | -0.109000 | 0.975 |
| MITF-M-regulated melanocyte development | 15 | 0.43200 | 0.118000 | 0.975 |
| Pre-NOTCH Processing in Golgi | 6 | 0.43200 | -0.186000 | 0.975 |
| HIV Infection | 17 | 0.43300 | -0.111000 | 0.975 |
| RHO GTPases activate CIT | 5 | 0.44200 | -0.199000 | 0.975 |
| Cilium Assembly | 18 | 0.44300 | -0.106000 | 0.975 |
| Interleukin-4 and Interleukin-13 signaling | 22 | 0.44400 | -0.095400 | 0.975 |
| Dengue Virus-Host Interactions | 18 | 0.44500 | -0.105000 | 0.975 |
| Scavenging by Class A Receptors | 11 | 0.44600 | -0.134000 | 0.975 |
| Signaling by EGFR | 5 | 0.44700 | -0.197000 | 0.975 |
| Kinesins | 6 | 0.44700 | 0.180000 | 0.975 |
| Endosomal/Vacuolar pathway | 5 | 0.45100 | -0.196000 | 0.975 |
| Listeria monocytogenes entry into host cells | 5 | 0.45200 | 0.195000 | 0.975 |
| Signaling by FGFR | 5 | 0.45600 | 0.193000 | 0.975 |
| Signaling by FGFR2 | 5 | 0.45600 | 0.193000 | 0.975 |
| CLEC7A (Dectin-1) signaling | 15 | 0.45900 | -0.112000 | 0.975 |
| Keratan sulfate/keratin metabolism | 7 | 0.45900 | 0.162000 | 0.975 |
| FLT3 Signaling | 5 | 0.46000 | 0.192000 | 0.975 |
| UCH proteinases | 13 | 0.46200 | -0.119000 | 0.975 |
| Signaling by MET | 13 | 0.46600 | -0.118000 | 0.975 |
| Metabolism of vitamins and cofactors | 27 | 0.47000 | -0.081600 | 0.975 |
| Degradation of CDH1 | 17 | 0.47100 | -0.102000 | 0.975 |
| Potential therapeutics for SARS | 46 | 0.47300 | -0.062800 | 0.975 |
| Regulation of actin dynamics for phagocytic cup formation | 62 | 0.47700 | -0.054100 | 0.975 |
| Signaling by NOTCH | 24 | 0.47900 | -0.084800 | 0.975 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | 12 | 0.48100 | -0.118000 | 0.975 |
| Regulation of expression of SLITs and ROBOs | 12 | 0.48200 | -0.118000 | 0.975 |
| Signaling by the B Cell Receptor (BCR) | 54 | 0.48200 | -0.057000 | 0.975 |
| Developmental Biology | 121 | 0.48700 | 0.039300 | 0.975 |
| RAF/MAP kinase cascade | 37 | 0.48800 | 0.067400 | 0.975 |
| Metabolism of water-soluble vitamins and cofactors | 10 | 0.48800 | -0.128000 | 0.975 |
| Rab regulation of trafficking | 12 | 0.48800 | -0.116000 | 0.975 |
| Signaling by Receptor Tyrosine Kinases | 49 | 0.49100 | -0.058500 | 0.975 |
| Signaling by Hedgehog | 21 | 0.49700 | 0.086800 | 0.975 |
| Signaling by NTRK1 (TRKA) | 6 | 0.49700 | 0.161000 | 0.975 |
| Dengue virus activates/modulates innate and adaptive immune responses | 12 | 0.50500 | -0.112000 | 0.975 |
| MAPK1/MAPK3 signaling | 38 | 0.50700 | 0.063500 | 0.975 |
| Transport of small molecules | 63 | 0.50800 | -0.050000 | 0.975 |
| Transmission across Chemical Synapses | 17 | 0.51100 | 0.093000 | 0.975 |
| Collagen biosynthesis and modifying enzymes | 8 | 0.51300 | 0.134000 | 0.975 |
| PIP3 activates AKT signaling | 20 | 0.51500 | -0.085100 | 0.975 |
| ABC-family proteins mediated transport | 14 | 0.51600 | -0.101000 | 0.975 |
| Signaling by TGF-beta Receptor Complex | 12 | 0.51800 | -0.109000 | 0.975 |
| HDL remodeling | 8 | 0.52000 | -0.132000 | 0.975 |
| Mitotic G1 phase and G1/S transition | 12 | 0.52000 | -0.108000 | 0.975 |
| Defective F9 activation | 6 | 0.52000 | -0.152000 | 0.975 |
| Defective factor VIII causes hemophilia A | 5 | 0.52200 | 0.166000 | 0.975 |
| Metabolism of polyamines | 10 | 0.52500 | -0.117000 | 0.975 |
| Regulation of ornithine decarboxylase (ODC) | 10 | 0.52500 | -0.117000 | 0.975 |
| Negative regulation of the PI3K/AKT network | 9 | 0.53000 | -0.122000 | 0.975 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 9 | 0.53000 | -0.122000 | 0.975 |
| G alpha (q) signalling events | 14 | 0.53100 | 0.097600 | 0.975 |
| Platelet Aggregation (Plug Formation) | 18 | 0.53200 | -0.086000 | 0.975 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | 17 | 0.54100 | -0.086500 | 0.975 |
| Metabolism of amino acids and derivatives | 20 | 0.54200 | -0.079600 | 0.975 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | 18 | 0.54400 | -0.083500 | 0.975 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 14 | 0.54600 | -0.094100 | 0.975 |
| Disorders of transmembrane transporters | 18 | 0.54800 | -0.082800 | 0.975 |
| Ub-specific processing proteases | 13 | 0.55300 | 0.095700 | 0.975 |
| Signaling by GPCR | 32 | 0.55500 | -0.061400 | 0.975 |
| Cytokine Signaling in Immune system | 77 | 0.55600 | -0.040600 | 0.975 |
| Elastic fibre formation | 10 | 0.55800 | -0.108000 | 0.975 |
| Molecules associated with elastic fibres | 10 | 0.55800 | -0.108000 | 0.975 |
| Cargo recognition for clathrin-mediated endocytosis | 10 | 0.55900 | 0.107000 | 0.975 |
| Defective Intrinsic Pathway for Apoptosis | 7 | 0.56000 | 0.128000 | 0.975 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models | 7 | 0.56000 | 0.128000 | 0.975 |
| Diseases of programmed cell death | 7 | 0.56000 | 0.128000 | 0.975 |
| Neurodegenerative Diseases | 7 | 0.56000 | 0.128000 | 0.975 |
| p130Cas linkage to MAPK signaling for integrins | 10 | 0.56100 | 0.107000 | 0.975 |
| Influenza Infection | 8 | 0.56400 | -0.119000 | 0.975 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 7 | 0.56400 | 0.127000 | 0.975 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 14 | 0.56600 | -0.089400 | 0.975 |
| Apoptotic cleavage of cellular proteins | 9 | 0.56700 | 0.111000 | 0.975 |
| Initial triggering of complement | 67 | 0.56900 | 0.041900 | 0.975 |
| Activation of BAD and translocation to mitochondria | 6 | 0.56900 | -0.135000 | 0.975 |
| Activation of BH3-only proteins | 6 | 0.56900 | -0.135000 | 0.975 |
| Pyruvate metabolism | 6 | 0.56900 | 0.135000 | 0.975 |
| Metabolism of fat-soluble vitamins | 13 | 0.57200 | -0.091300 | 0.975 |
| Retinoid metabolism and transport | 13 | 0.57200 | -0.091300 | 0.975 |
| Intracellular signaling by second messengers | 22 | 0.57600 | -0.069800 | 0.975 |
| ER to Golgi Anterograde Transport | 23 | 0.58000 | 0.067600 | 0.975 |
| Opioid Signalling | 8 | 0.58000 | 0.114000 | 0.975 |
| Antimicrobial peptides | 14 | 0.58100 | -0.086000 | 0.975 |
| Interferon gamma signaling | 9 | 0.58100 | 0.107000 | 0.975 |
| Detoxification of Reactive Oxygen Species | 15 | 0.58100 | -0.083000 | 0.975 |
| RHO GTPases Activate ROCKs | 7 | 0.58300 | -0.121000 | 0.975 |
| Sema3A PAK dependent Axon repulsion | 5 | 0.58300 | -0.142000 | 0.975 |
| MAPK family signaling cascades | 40 | 0.58700 | 0.050800 | 0.975 |
| GPCR downstream signalling | 30 | 0.58800 | -0.058200 | 0.975 |
| EML4 and NUDC in mitotic spindle formation | 7 | 0.59500 | 0.117000 | 0.975 |
| Resolution of Sister Chromatid Cohesion | 7 | 0.59500 | 0.117000 | 0.975 |
| Terminal pathway of complement | 8 | 0.59600 | 0.109000 | 0.975 |
| Post-translational modification: synthesis of GPI-anchored proteins | 9 | 0.60500 | -0.100000 | 0.975 |
| DAP12 interactions | 6 | 0.60700 | -0.122000 | 0.975 |
| Clathrin-mediated endocytosis | 19 | 0.60800 | -0.068800 | 0.975 |
| G2/M Transition | 24 | 0.61000 | -0.061000 | 0.975 |
| Mitotic G2-G2/M phases | 24 | 0.61000 | -0.061000 | 0.975 |
| Regulation of CDH1 Expression and Function | 26 | 0.61200 | -0.058300 | 0.975 |
| Regulation of Expression and Function of Type I Classical Cadherins | 26 | 0.61200 | -0.058300 | 0.975 |
| Regulation of Homotypic Cell-Cell Adhesion | 26 | 0.61200 | -0.058300 | 0.975 |
| FOXO-mediated transcription | 6 | 0.61500 | 0.119000 | 0.975 |
| Hedgehog ‘off’ state | 16 | 0.61700 | 0.072900 | 0.975 |
| Hh mutants abrogate ligand secretion | 14 | 0.61700 | -0.077800 | 0.975 |
| Signaling by CSF1 (M-CSF) in myeloid cells | 5 | 0.61900 | 0.129000 | 0.975 |
| Interleukin-12 signaling | 15 | 0.61900 | -0.074800 | 0.975 |
| Chylomicron remodeling | 9 | 0.62100 | -0.095700 | 0.975 |
| Binding and Uptake of Ligands by Scavenger Receptors | 74 | 0.62700 | -0.034100 | 0.975 |
| FCERI mediated NF-kB activation | 57 | 0.62900 | -0.038200 | 0.975 |
| SARS-CoV Infections | 73 | 0.63100 | -0.033900 | 0.975 |
| RHO GTPases activate PKNs | 10 | 0.63200 | -0.087900 | 0.975 |
| Signal amplification | 5 | 0.63500 | -0.123000 | 0.975 |
| Anchoring of the basal body to the plasma membrane | 10 | 0.63700 | -0.086800 | 0.975 |
| Extracellular matrix organization | 66 | 0.63800 | -0.034800 | 0.975 |
| Neurotransmitter receptors and postsynaptic signal transmission | 13 | 0.63800 | 0.075900 | 0.975 |
| SARS-CoV-1-host interactions | 11 | 0.63900 | -0.082400 | 0.975 |
| Mitotic Prometaphase | 12 | 0.64400 | 0.077500 | 0.975 |
| Antigen processing: Ubiquitination & Proteasome degradation | 16 | 0.64500 | -0.067100 | 0.975 |
| Antigen processing-Cross presentation | 27 | 0.64500 | -0.052000 | 0.975 |
| MAPK6/MAPK4 signaling | 13 | 0.64600 | -0.074200 | 0.975 |
| Role of phospholipids in phagocytosis | 48 | 0.64900 | -0.039000 | 0.975 |
| Mitochondrial unfolded protein response (UPRmt) | 5 | 0.65700 | 0.115000 | 0.975 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 12 | 0.66400 | -0.073100 | 0.975 |
| Defective CFTR causes cystic fibrosis | 12 | 0.66400 | -0.073100 | 0.975 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 12 | 0.66400 | -0.073100 | 0.975 |
| Ribosome-associated quality control | 12 | 0.66400 | -0.073100 | 0.975 |
| RHO GTPases Activate WASPs and WAVEs | 10 | 0.66800 | -0.079000 | 0.975 |
| Metabolism of nucleotides | 9 | 0.67000 | -0.082600 | 0.975 |
| Hedgehog ligand biogenesis | 15 | 0.67100 | -0.064000 | 0.975 |
| Beta-catenin independent WNT signaling | 16 | 0.67500 | -0.061100 | 0.975 |
| Regulation of insulin secretion | 6 | 0.67900 | 0.098000 | 0.975 |
| Metabolism of RNA | 23 | 0.67900 | -0.050500 | 0.975 |
| Amyloid fiber formation | 18 | 0.68600 | 0.055700 | 0.975 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 41 | 0.69100 | -0.036800 | 0.975 |
| Creation of C4 and C2 activators | 60 | 0.69100 | 0.030700 | 0.975 |
| TP53 Regulates Metabolic Genes | 12 | 0.69300 | -0.066300 | 0.975 |
| TCR signaling | 16 | 0.69400 | 0.057400 | 0.975 |
| Integrin signaling | 13 | 0.69800 | 0.062600 | 0.975 |
| Assembly of active LPL and LIPC lipase complexes | 5 | 0.69900 | 0.100000 | 0.975 |
| Fc epsilon receptor (FCERI) signaling | 62 | 0.69900 | -0.029400 | 0.975 |
| Regulation of TLR by endogenous ligand | 8 | 0.70100 | -0.079000 | 0.975 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 19 | 0.70400 | 0.051000 | 0.975 |
| Biological oxidations | 19 | 0.70600 | -0.050500 | 0.975 |
| Post NMDA receptor activation events | 9 | 0.70800 | 0.072600 | 0.975 |
| COPI-mediated anterograde transport | 16 | 0.71200 | 0.053900 | 0.975 |
| Visual phototransduction | 15 | 0.71200 | -0.055600 | 0.975 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 6 | 0.72000 | 0.085000 | 0.975 |
| Plasma lipoprotein assembly, remodeling, and clearance | 24 | 0.72200 | -0.042600 | 0.975 |
| Gap junction trafficking and regulation | 8 | 0.72800 | -0.071400 | 0.975 |
| RAB GEFs exchange GTP for GDP on RABs | 11 | 0.72800 | -0.061000 | 0.975 |
| Proteasome assembly | 12 | 0.72900 | -0.058100 | 0.975 |
| PCP/CE pathway | 13 | 0.72900 | -0.055900 | 0.975 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 59 | 0.73000 | -0.026900 | 0.975 |
| Neddylation | 14 | 0.73300 | -0.053100 | 0.975 |
| Negative regulation of NOTCH4 signaling | 12 | 0.73400 | -0.057000 | 0.975 |
| TCF dependent signaling in response to WNT | 12 | 0.73400 | -0.057000 | 0.975 |
| Deubiquitination | 17 | 0.73500 | -0.047900 | 0.975 |
| Protein localization | 9 | 0.73800 | -0.064700 | 0.975 |
| Regulated Necrosis | 5 | 0.73900 | 0.086500 | 0.975 |
| RND1 GTPase cycle | 5 | 0.74000 | -0.086100 | 0.975 |
| RHOC GTPase cycle | 9 | 0.74100 | 0.063900 | 0.975 |
| NR1H2 and NR1H3-mediated signaling | 8 | 0.74800 | 0.065800 | 0.975 |
| G alpha (s) signalling events | 8 | 0.75400 | -0.064500 | 0.975 |
| Factors involved in megakaryocyte development and platelet production | 13 | 0.75500 | 0.050500 | 0.975 |
| Defective factor IX causes hemophilia B | 8 | 0.75700 | -0.063600 | 0.975 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 61 | 0.75700 | 0.023700 | 0.975 |
| MITF-M-dependent gene expression | 8 | 0.76000 | 0.062800 | 0.975 |
| APC/C-mediated degradation of cell cycle proteins | 11 | 0.76100 | -0.053400 | 0.975 |
| APC/C:Cdc20 mediated degradation of Securin | 11 | 0.76100 | -0.053400 | 0.975 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | 11 | 0.76100 | -0.053400 | 0.975 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 11 | 0.76100 | -0.053400 | 0.975 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 11 | 0.76100 | -0.053400 | 0.975 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 11 | 0.76100 | -0.053400 | 0.975 |
| Activation of NF-kappaB in B cells | 11 | 0.76100 | -0.053400 | 0.975 |
| Assembly of the pre-replicative complex | 11 | 0.76100 | -0.053400 | 0.975 |
| Asymmetric localization of PCP proteins | 11 | 0.76100 | -0.053400 | 0.975 |
| Autodegradation of Cdh1 by Cdh1:APC/C | 11 | 0.76100 | -0.053400 | 0.975 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 11 | 0.76100 | -0.053400 | 0.975 |
| CDK-mediated phosphorylation and removal of Cdc6 | 11 | 0.76100 | -0.053400 | 0.975 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 11 | 0.76100 | -0.053400 | 0.975 |
| Cellular response to hypoxia | 11 | 0.76100 | -0.053400 | 0.975 |
| Cyclin A:Cdk2-associated events at S phase entry | 11 | 0.76100 | -0.053400 | 0.975 |
| Cyclin E associated events during G1/S transition | 11 | 0.76100 | -0.053400 | 0.975 |
| DNA Replication | 11 | 0.76100 | -0.053400 | 0.975 |
| DNA Replication Pre-Initiation | 11 | 0.76100 | -0.053400 | 0.975 |
| Dectin-1 mediated noncanonical NF-kB signaling | 11 | 0.76100 | -0.053400 | 0.975 |
| Degradation of AXIN | 11 | 0.76100 | -0.053400 | 0.975 |
| Degradation of CRY and PER proteins | 11 | 0.76100 | -0.053400 | 0.975 |
| Degradation of DVL | 11 | 0.76100 | -0.053400 | 0.975 |
| Degradation of GLI1 by the proteasome | 11 | 0.76100 | -0.053400 | 0.975 |
| Degradation of GLI2 by the proteasome | 11 | 0.76100 | -0.053400 | 0.975 |
| Degradation of beta-catenin by the destruction complex | 11 | 0.76100 | -0.053400 | 0.975 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 11 | 0.76100 | -0.053400 | 0.975 |
| G1/S DNA Damage Checkpoints | 11 | 0.76100 | -0.053400 | 0.975 |
| G1/S Transition | 11 | 0.76100 | -0.053400 | 0.975 |
| GLI3 is processed to GLI3R by the proteasome | 11 | 0.76100 | -0.053400 | 0.975 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 11 | 0.76100 | -0.053400 | 0.975 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 11 | 0.76100 | -0.053400 | 0.975 |
| NIK–>noncanonical NF-kB signaling | 11 | 0.76100 | -0.053400 | 0.975 |
| Orc1 removal from chromatin | 11 | 0.76100 | -0.053400 | 0.975 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 11 | 0.76100 | -0.053400 | 0.975 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of APC/C activators between G1/S and early anaphase | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of Apoptosis | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of PTEN stability and activity | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of RAS by GAPs | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of RUNX2 expression and activity | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 11 | 0.76100 | -0.053400 | 0.975 |
| Regulation of mitotic cell cycle | 11 | 0.76100 | -0.053400 | 0.975 |
| S Phase | 11 | 0.76100 | -0.053400 | 0.975 |
| SCF(Skp2)-mediated degradation of p27/p21 | 11 | 0.76100 | -0.053400 | 0.975 |
| SCF-beta-TrCP mediated degradation of Emi1 | 11 | 0.76100 | -0.053400 | 0.975 |
| Stabilization of p53 | 11 | 0.76100 | -0.053400 | 0.975 |
| Switching of origins to a post-replicative state | 11 | 0.76100 | -0.053400 | 0.975 |
| Synthesis of DNA | 11 | 0.76100 | -0.053400 | 0.975 |
| TNFR2 non-canonical NF-kB pathway | 11 | 0.76100 | -0.053400 | 0.975 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 11 | 0.76100 | -0.053400 | 0.975 |
| Ubiquitin-dependent degradation of Cyclin D | 11 | 0.76100 | -0.053400 | 0.975 |
| Vif-mediated degradation of APOBEC3G | 11 | 0.76100 | -0.053400 | 0.975 |
| Vpu mediated degradation of CD4 | 11 | 0.76100 | -0.053400 | 0.975 |
| p53-Dependent G1 DNA Damage Response | 11 | 0.76100 | -0.053400 | 0.975 |
| p53-Dependent G1/S DNA damage checkpoint | 11 | 0.76100 | -0.053400 | 0.975 |
| p53-Independent G1/S DNA Damage Checkpoint | 11 | 0.76100 | -0.053400 | 0.975 |
| FCERI mediated MAPK activation | 47 | 0.76100 | 0.026400 | 0.975 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | 11 | 0.76300 | -0.052800 | 0.975 |
| G alpha (i) signalling events | 19 | 0.76300 | 0.040400 | 0.975 |
| SLC-mediated transmembrane transport | 6 | 0.76300 | 0.071300 | 0.975 |
| Toll-like Receptor Cascades | 17 | 0.76400 | 0.042500 | 0.975 |
| Signaling by ERBB4 | 6 | 0.76800 | -0.069800 | 0.975 |
| Attachment of bacteria to epithelial cells | 5 | 0.77100 | -0.075400 | 0.975 |
| Biofilm formation | 5 | 0.77100 | -0.075400 | 0.975 |
| Nuclear Envelope (NE) Reassembly | 6 | 0.77400 | 0.067900 | 0.975 |
| RAC1 GTPase cycle | 8 | 0.77400 | -0.058900 | 0.975 |
| Integration of energy metabolism | 10 | 0.77600 | -0.052300 | 0.975 |
| Gluconeogenesis | 9 | 0.77900 | 0.054300 | 0.975 |
| Glycogen metabolism | 6 | 0.78000 | 0.066100 | 0.975 |
| Signaling by ALK fusions and activated point mutants | 14 | 0.78100 | -0.043300 | 0.975 |
| Signaling by ALK in cancer | 14 | 0.78100 | -0.043300 | 0.975 |
| Classical antibody-mediated complement activation | 52 | 0.78100 | -0.023000 | 0.975 |
| SLC transporter disorders | 5 | 0.78200 | 0.071900 | 0.975 |
| Interferon Signaling | 20 | 0.78200 | 0.036200 | 0.975 |
| Transcriptional regulation by RUNX2 | 15 | 0.78200 | -0.041600 | 0.975 |
| RAC2 GTPase cycle | 6 | 0.78300 | -0.065300 | 0.975 |
| Signaling by Interleukins | 60 | 0.78400 | -0.021200 | 0.975 |
| Response of Mtb to phagocytosis | 6 | 0.78600 | 0.064200 | 0.975 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 9 | 0.78700 | 0.052300 | 0.975 |
| RHO GTPases activate IQGAPs | 9 | 0.78700 | 0.052300 | 0.975 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 12 | 0.79200 | -0.044300 | 0.976 |
| Cell Cycle, Mitotic | 30 | 0.79300 | -0.028100 | 0.976 |
| Iron uptake and transport | 9 | 0.79300 | 0.050800 | 0.976 |
| Signaling by ERBB2 | 7 | 0.79400 | -0.057200 | 0.976 |
| M Phase | 27 | 0.80000 | 0.028700 | 0.980 |
| Downstream TCR signaling | 12 | 0.80400 | -0.041700 | 0.984 |
| Plasma lipoprotein clearance | 8 | 0.80700 | 0.050200 | 0.985 |
| Regulation of PLK1 Activity at G2/M Transition | 10 | 0.81200 | 0.043600 | 0.988 |
| Signaling by SCF-KIT | 5 | 0.81600 | -0.060300 | 0.988 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | 5 | 0.81700 | 0.059800 | 0.988 |
| CD22 mediated BCR regulation | 37 | 0.82000 | -0.022000 | 0.988 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 13 | 0.82500 | 0.035700 | 0.988 |
| Assembly of collagen fibrils and other multimeric structures | 10 | 0.82900 | 0.039600 | 0.988 |
| PTEN Regulation | 12 | 0.83400 | 0.035300 | 0.988 |
| Activation of AMPK downstream of NMDARs | 6 | 0.83500 | -0.049400 | 0.988 |
| Cargo concentration in the ER | 6 | 0.83500 | 0.049400 | 0.988 |
| Signaling by PDGF | 8 | 0.83600 | 0.042400 | 0.988 |
| RHOB GTPase cycle | 10 | 0.83700 | -0.037800 | 0.988 |
| Bacterial Infection Pathways | 25 | 0.83700 | 0.024100 | 0.988 |
| G2/M Checkpoints | 16 | 0.84100 | -0.029300 | 0.988 |
| Recycling pathway of L1 | 11 | 0.84100 | 0.035100 | 0.988 |
| Circadian clock | 14 | 0.84300 | -0.030800 | 0.988 |
| SARS-CoV-2-host interactions | 16 | 0.84300 | -0.028900 | 0.988 |
| Macroautophagy | 14 | 0.84600 | 0.030200 | 0.988 |
| Selective autophagy | 14 | 0.84600 | 0.030200 | 0.988 |
| SARS-CoV-2 Infection | 25 | 0.84700 | 0.022600 | 0.988 |
| Role of LAT2/NTAL/LAB on calcium mobilization | 47 | 0.84800 | -0.016600 | 0.988 |
| Scavenging of heme from plasma | 55 | 0.84900 | 0.015300 | 0.988 |
| Activation of C3 and C5 | 7 | 0.85200 | 0.040900 | 0.988 |
| RHOJ GTPase cycle | 6 | 0.85400 | 0.043400 | 0.988 |
| RHOQ GTPase cycle | 6 | 0.85400 | 0.043400 | 0.988 |
| Mitotic Anaphase | 19 | 0.85500 | 0.024400 | 0.988 |
| Mitotic Metaphase and Anaphase | 19 | 0.85500 | 0.024400 | 0.988 |
| Glucose metabolism | 15 | 0.85600 | -0.027400 | 0.988 |
| Glycolysis | 15 | 0.85600 | -0.027400 | 0.988 |
| Vesicle-mediated transport | 138 | 0.85600 | -0.009670 | 0.988 |
| Plasma lipoprotein assembly | 12 | 0.86100 | -0.029300 | 0.992 |
| Chaperone Mediated Autophagy | 9 | 0.86300 | 0.033400 | 0.992 |
| Aggrephagy | 11 | 0.86500 | 0.029800 | 0.992 |
| Signaling by Nuclear Receptors | 24 | 0.87400 | -0.018900 | 0.993 |
| Infection with Enterobacteria | 8 | 0.87500 | 0.032400 | 0.993 |
| Diseases of metabolism | 32 | 0.88100 | 0.015600 | 0.993 |
| Activated NOTCH1 Transmits Signal to the Nucleus | 5 | 0.88300 | -0.038000 | 0.993 |
| Signaling by NOTCH1 | 5 | 0.88300 | -0.038000 | 0.993 |
| Metabolism of proteins | 201 | 0.88400 | 0.006770 | 0.993 |
| CDC42 GTPase cycle | 8 | 0.88800 | 0.029000 | 0.993 |
| Assembly and cell surface presentation of NMDA receptors | 5 | 0.88900 | 0.036300 | 0.993 |
| Carboxyterminal post-translational modifications of tubulin | 5 | 0.88900 | 0.036300 | 0.993 |
| Gap junction assembly | 5 | 0.88900 | 0.036300 | 0.993 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 5 | 0.88900 | 0.036300 | 0.993 |
| Post-chaperonin tubulin folding pathway | 5 | 0.88900 | 0.036300 | 0.993 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | 5 | 0.88900 | 0.036300 | 0.993 |
| Transport of connexons to the plasma membrane | 5 | 0.88900 | 0.036300 | 0.993 |
| Post-translational protein modification | 148 | 0.89100 | -0.007130 | 0.993 |
| Intrinsic Pathway for Apoptosis | 7 | 0.89800 | 0.028200 | 0.993 |
| RHOD GTPase cycle | 8 | 0.90100 | -0.025700 | 0.993 |
| Signaling by TGFB family members | 16 | 0.90200 | 0.018000 | 0.993 |
| SARS-CoV-1 Infection | 16 | 0.91000 | -0.016500 | 0.993 |
| L1CAM interactions | 27 | 0.91200 | 0.012500 | 0.993 |
| Golgi-to-ER retrograde transport | 15 | 0.91200 | -0.016600 | 0.993 |
| RHOG GTPase cycle | 9 | 0.91600 | -0.020500 | 0.993 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | 5 | 0.91700 | -0.026900 | 0.993 |
| Pre-NOTCH Expression and Processing | 7 | 0.91700 | -0.022800 | 0.993 |
| Neuronal System | 24 | 0.92200 | 0.011700 | 0.993 |
| Hedgehog ‘on’ state | 14 | 0.92300 | 0.015100 | 0.993 |
| CHL1 interactions | 6 | 0.92400 | 0.022600 | 0.993 |
| Apoptotic execution phase | 10 | 0.92400 | 0.017400 | 0.993 |
| Separation of Sister Chromatids | 18 | 0.92500 | 0.013000 | 0.993 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 5 | 0.92500 | 0.024200 | 0.993 |
| G2/M DNA damage checkpoint | 5 | 0.92500 | 0.024200 | 0.993 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 5 | 0.92500 | 0.024200 | 0.993 |
| G alpha (12/13) signalling events | 5 | 0.92500 | -0.024200 | 0.993 |
| Dengue Virus Attachment and Entry | 7 | 0.92700 | -0.020200 | 0.993 |
| Phase I - Functionalization of compounds | 10 | 0.92800 | -0.016600 | 0.993 |
| MHC class II antigen presentation | 18 | 0.92900 | 0.012300 | 0.993 |
| RHO GTPases Activate Formins | 13 | 0.93000 | 0.014200 | 0.993 |
| Gap junction trafficking | 7 | 0.93100 | 0.019000 | 0.993 |
| Signal transduction by L1 | 8 | 0.93300 | 0.017300 | 0.993 |
| COPII-mediated vesicle transport | 9 | 0.93400 | -0.016000 | 0.993 |
| Regulation of HSF1-mediated heat shock response | 8 | 0.93700 | 0.016200 | 0.993 |
| FCERI mediated Ca+2 mobilization | 47 | 0.93900 | -0.006680 | 0.993 |
| RHOF GTPase cycle | 9 | 0.94000 | 0.014500 | 0.993 |
| Cell Cycle Checkpoints | 18 | 0.94400 | 0.009660 | 0.993 |
| Collagen formation | 12 | 0.95000 | 0.010500 | 0.993 |
| Hh mutants are degraded by ERAD | 13 | 0.95100 | -0.009930 | 0.993 |
| Integrin cell surface interactions | 28 | 0.95400 | -0.006360 | 0.993 |
| Cell recruitment (pro-inflammatory response) | 5 | 0.95600 | 0.014500 | 0.993 |
| Purinergic signaling in leishmaniasis infection | 5 | 0.95600 | 0.014500 | 0.993 |
| Diseases associated with the TLR signaling cascade | 6 | 0.95700 | -0.012600 | 0.993 |
| Diseases of Immune System | 6 | 0.95700 | -0.012600 | 0.993 |
| IRAK4 deficiency (TLR2/4) | 6 | 0.95700 | -0.012600 | 0.993 |
| MyD88 deficiency (TLR2/4) | 6 | 0.95700 | -0.012600 | 0.993 |
| Autophagy | 19 | 0.95800 | 0.007080 | 0.993 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 5 | 0.95800 | 0.013600 | 0.993 |
| Programmed Cell Death | 33 | 0.95900 | -0.005320 | 0.993 |
| COPI-dependent Golgi-to-ER retrograde traffic | 11 | 0.96600 | -0.007430 | 0.993 |
| PKR-mediated signaling | 7 | 0.96700 | -0.009080 | 0.993 |
| Post-translational protein phosphorylation | 53 | 0.97100 | 0.002950 | 0.993 |
| GPCR ligand binding | 15 | 0.97200 | 0.005320 | 0.993 |
| Diseases of hemostasis | 14 | 0.97500 | 0.004980 | 0.993 |
| Class A/1 (Rhodopsin-like receptors) | 11 | 0.97600 | 0.005190 | 0.993 |
| Peptide ligand-binding receptors | 11 | 0.97600 | 0.005190 | 0.993 |
| Signaling by NTRKs | 7 | 0.97900 | 0.005890 | 0.993 |
| Antimicrobial mechanism of IFN-stimulated genes | 10 | 0.98100 | -0.004470 | 0.993 |
| Interleukin-1 family signaling | 15 | 0.98600 | -0.002620 | 0.993 |
| Interleukin-1 signaling | 15 | 0.98600 | -0.002620 | 0.993 |
| AURKA Activation by TPX2 | 8 | 0.98700 | 0.003350 | 0.993 |
| Centrosome maturation | 8 | 0.98700 | 0.003350 | 0.993 |
| Loss of Nlp from mitotic centrosomes | 8 | 0.98700 | 0.003350 | 0.993 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 8 | 0.98700 | 0.003350 | 0.993 |
| Recruitment of mitotic centrosome proteins and complexes | 8 | 0.98700 | 0.003350 | 0.993 |
| Membrane Trafficking | 67 | 0.98700 | -0.001190 | 0.993 |
| Recruitment of NuMA to mitotic centrosomes | 11 | 0.98900 | 0.002340 | 0.993 |
| COPI-independent Golgi-to-ER retrograde traffic | 9 | 0.99200 | 0.001860 | 0.993 |
| Cell Cycle | 33 | 0.99300 | -0.000939 | 0.993 |
| Apoptosis | 29 | 0.99300 | -0.000906 | 0.993 |
| set | Metabolism of lipids |
| setSize | 30 |
| pANOVA | 0.00166 |
| s.dist | -0.337 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| GPX1 | -393 |
| APOA1 | -385 |
| ALB | -366 |
| DECR1 | -362 |
| MGLL | -350 |
| PON1 | -335 |
| PIP4K2A | -320 |
| RAB14 | -316 |
| TSPO | -296 |
| ACLY | -291 |
| ARF3 | -279 |
| GC | -254 |
| APOA2 | -249 |
| HEXB | -224 |
| TBXAS1 | -161 |
| PTGS1 | -132 |
| PPP1CA | -113 |
| GBA1 | -91 |
| DPEP2 | -44 |
| PON3 | 11 |
| GeneID | Gene Rank |
|---|---|
| GPX1 | -393 |
| APOA1 | -385 |
| ALB | -366 |
| DECR1 | -362 |
| MGLL | -350 |
| PON1 | -335 |
| PIP4K2A | -320 |
| RAB14 | -316 |
| TSPO | -296 |
| ACLY | -291 |
| ARF3 | -279 |
| GC | -254 |
| APOA2 | -249 |
| HEXB | -224 |
| TBXAS1 | -161 |
| PTGS1 | -132 |
| PPP1CA | -113 |
| GBA1 | -91 |
| DPEP2 | -44 |
| PON3 | 11 |
| FABP5 | 17 |
| EPHX2 | 19 |
| SERPINA6 | 30 |
| RAN | 147 |
| LTA4H | 170 |
| APOA5 | 180 |
| PTGDS | 250 |
| BCHE | 263 |
| AGT | 346 |
| GM2A | 479 |
| set | Peptide hormone metabolism |
| setSize | 15 |
| pANOVA | 0.00394 |
| s.dist | 0.433 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| IGF1 | 491 |
| CTSZ | 481 |
| GNB1 | 418 |
| AGT | 346 |
| INHBE | 290 |
| CPB2 | 282 |
| BCHE | 263 |
| CTSD | 252 |
| ACE | 166 |
| PLA2G7 | 157 |
| DPP4 | 150 |
| INHBC | 141 |
| ANPEP | 140 |
| P4HB | 104 |
| CES1 | -112 |
| GeneID | Gene Rank |
|---|---|
| IGF1 | 491 |
| CTSZ | 481 |
| GNB1 | 418 |
| AGT | 346 |
| INHBE | 290 |
| CPB2 | 282 |
| BCHE | 263 |
| CTSD | 252 |
| ACE | 166 |
| PLA2G7 | 157 |
| DPP4 | 150 |
| INHBC | 141 |
| ANPEP | 140 |
| P4HB | 104 |
| CES1 | -112 |
| set | Formation of the cornified envelope |
| setSize | 28 |
| pANOVA | 0.00414 |
| s.dist | 0.318 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| PKP1 | 465 |
| KRT71 | 404 |
| KRT77 | 365 |
| FLG | 352 |
| KRT6C | 328 |
| DSP | 321 |
| CAPN1 | 310 |
| DSG1 | 303 |
| JUP | 302 |
| KRT17 | 295 |
| CASP14 | 288 |
| KRT9 | 287 |
| KRT14 | 259 |
| KRT78 | 258 |
| KRT5 | 254 |
| DSC1 | 233 |
| KRT16 | 193 |
| KRT1 | 181 |
| EVPL | 165 |
| KRT6A | 162 |
| GeneID | Gene Rank |
|---|---|
| PKP1 | 465 |
| KRT71 | 404 |
| KRT77 | 365 |
| FLG | 352 |
| KRT6C | 328 |
| DSP | 321 |
| CAPN1 | 310 |
| DSG1 | 303 |
| JUP | 302 |
| KRT17 | 295 |
| CASP14 | 288 |
| KRT9 | 287 |
| KRT14 | 259 |
| KRT78 | 258 |
| KRT5 | 254 |
| DSC1 | 233 |
| KRT16 | 193 |
| KRT1 | 181 |
| EVPL | 165 |
| KRT6A | 162 |
| KRT80 | 106 |
| KRT2 | 12 |
| KRT10 | 1 |
| DSG2 | -49 |
| SPINK5 | -63 |
| CSTA | -128 |
| CAPNS1 | -137 |
| TGM1 | -299 |
| set | Keratinization |
| setSize | 28 |
| pANOVA | 0.00414 |
| s.dist | 0.318 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| PKP1 | 465 |
| KRT71 | 404 |
| KRT77 | 365 |
| FLG | 352 |
| KRT6C | 328 |
| DSP | 321 |
| CAPN1 | 310 |
| DSG1 | 303 |
| JUP | 302 |
| KRT17 | 295 |
| CASP14 | 288 |
| KRT9 | 287 |
| KRT14 | 259 |
| KRT78 | 258 |
| KRT5 | 254 |
| DSC1 | 233 |
| KRT16 | 193 |
| KRT1 | 181 |
| EVPL | 165 |
| KRT6A | 162 |
| GeneID | Gene Rank |
|---|---|
| PKP1 | 465 |
| KRT71 | 404 |
| KRT77 | 365 |
| FLG | 352 |
| KRT6C | 328 |
| DSP | 321 |
| CAPN1 | 310 |
| DSG1 | 303 |
| JUP | 302 |
| KRT17 | 295 |
| CASP14 | 288 |
| KRT9 | 287 |
| KRT14 | 259 |
| KRT78 | 258 |
| KRT5 | 254 |
| DSC1 | 233 |
| KRT16 | 193 |
| KRT1 | 181 |
| EVPL | 165 |
| KRT6A | 162 |
| KRT80 | 106 |
| KRT2 | 12 |
| KRT10 | 1 |
| DSG2 | -49 |
| SPINK5 | -63 |
| CSTA | -128 |
| CAPNS1 | -137 |
| TGM1 | -299 |
| set | Platelet Adhesion to exposed collagen |
| setSize | 10 |
| pANOVA | 0.00456 |
| s.dist | -0.52 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| ITGA2 | -361 |
| GP1BA | -346 |
| ITGB1 | -258 |
| FCER1G | -242 |
| GP1BB | -197 |
| ADAMTS13 | -130 |
| GP5 | -126 |
| GP9 | 25 |
| VWF | 133 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| ITGA2 | -361 |
| GP1BA | -346 |
| ITGB1 | -258 |
| FCER1G | -242 |
| GP1BB | -197 |
| ADAMTS13 | -130 |
| GP5 | -126 |
| GP9 | 25 |
| VWF | 133 |
| set | Syndecan interactions |
| setSize | 10 |
| pANOVA | 0.00535 |
| s.dist | -0.511 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| ITGA6 | -401 |
| ITGA2 | -361 |
| ITGB1 | -258 |
| TGFB1 | -225 |
| THBS1 | -199 |
| TNC | -140 |
| ITGB3 | -98 |
| ACTN1 | -96 |
| VTN | -26 |
| FN1 | -25 |
| GeneID | Gene Rank |
|---|---|
| ITGA6 | -401 |
| ITGA2 | -361 |
| ITGB1 | -258 |
| TGFB1 | -225 |
| THBS1 | -199 |
| TNC | -140 |
| ITGB3 | -98 |
| ACTN1 | -96 |
| VTN | -26 |
| FN1 | -25 |
| set | Diseases associated with O-glycosylation of proteins |
| setSize | 9 |
| pANOVA | 0.00569 |
| s.dist | -0.534 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| NOTCH1 | -365 |
| DAG1 | -324 |
| SPON1 | -321 |
| NOTCH2 | -231 |
| THBS1 | -199 |
| B4GAT1 | -189 |
| ADAMTS13 | -130 |
| NOTCH3 | -93 |
| CFP | 109 |
| GeneID | Gene Rank |
|---|---|
| NOTCH1 | -365 |
| DAG1 | -324 |
| SPON1 | -321 |
| NOTCH2 | -231 |
| THBS1 | -199 |
| B4GAT1 | -189 |
| ADAMTS13 | -130 |
| NOTCH3 | -93 |
| CFP | 109 |
| set | Non-integrin membrane-ECM interactions |
| setSize | 19 |
| pANOVA | 0.00649 |
| s.dist | -0.364 |
| p.adjustANOVA | 0.488 |
| GeneID | Gene Rank |
|---|---|
| ITGA6 | -401 |
| ITGA2 | -361 |
| LAMC1 | -356 |
| DAG1 | -324 |
| ITGB1 | -258 |
| TGFB1 | -225 |
| THBS1 | -199 |
| TNC | -140 |
| ACTB | -109 |
| ITGB3 | -98 |
| ACTN1 | -96 |
| VTN | -26 |
| FN1 | -25 |
| HSPG2 | -15 |
| TTR | -7 |
| ACTC1 | 4 |
| LAMB1 | 28 |
| LAMA2 | 34 |
| COL4A1 | 377 |
| GeneID | Gene Rank |
|---|---|
| ITGA6 | -401 |
| ITGA2 | -361 |
| LAMC1 | -356 |
| DAG1 | -324 |
| ITGB1 | -258 |
| TGFB1 | -225 |
| THBS1 | -199 |
| TNC | -140 |
| ACTB | -109 |
| ITGB3 | -98 |
| ACTN1 | -96 |
| VTN | -26 |
| FN1 | -25 |
| HSPG2 | -15 |
| TTR | -7 |
| ACTC1 | 4 |
| LAMB1 | 28 |
| LAMA2 | 34 |
| COL4A1 | 377 |
| set | Neutrophil degranulation |
| setSize | 152 |
| pANOVA | 0.00733 |
| s.dist | 0.138 |
| p.adjustANOVA | 0.49 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 497 |
| PRCP | 486 |
| CTSZ | 481 |
| GM2A | 479 |
| HP | 476 |
| ELANE | 475 |
| PSMD3 | 473 |
| RAP1B | 472 |
| GPI | 469 |
| B4GALT1 | 468 |
| CSTB | 467 |
| MLEC | 466 |
| PKP1 | 465 |
| LILRA3 | 464 |
| DIAPH1 | 460 |
| CAT | 456 |
| CHI3L1 | 437 |
| RAB10 | 430 |
| LAMP2 | 426 |
| OSCAR | 423 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 497 |
| PRCP | 486 |
| CTSZ | 481 |
| GM2A | 479 |
| HP | 476 |
| ELANE | 475 |
| PSMD3 | 473 |
| RAP1B | 472 |
| GPI | 469 |
| B4GALT1 | 468 |
| CSTB | 467 |
| MLEC | 466 |
| PKP1 | 465 |
| LILRA3 | 464 |
| DIAPH1 | 460 |
| CAT | 456 |
| CHI3L1 | 437 |
| RAB10 | 430 |
| LAMP2 | 426 |
| OSCAR | 423 |
| FGL2 | 405 |
| ADA2 | 401 |
| AHSG | 400 |
| CD44 | 398 |
| TXNDC5 | 396 |
| PIGR | 390 |
| PGM1 | 387 |
| IQGAP2 | 383 |
| IDH1 | 381 |
| CAMP | 380 |
| SERPINB12 | 378 |
| B2M | 376 |
| PSMD2 | 363 |
| CST3 | 357 |
| LYZ | 353 |
| GRN | 342 |
| GGH | 337 |
| HRNR | 326 |
| LGALS3 | 322 |
| DSP | 321 |
| CFD | 315 |
| SERPINA3 | 311 |
| CAPN1 | 310 |
| PRSS3 | 307 |
| DSG1 | 303 |
| JUP | 302 |
| PTPRJ | 299 |
| CTSS | 289 |
| HBB | 286 |
| ORM1 | 276 |
| ALAD | 275 |
| PNP | 267 |
| BST1 | 262 |
| MMP9 | 260 |
| LTF | 257 |
| CTSD | 252 |
| TIMP2 | 247 |
| QSOX1 | 238 |
| ORM2 | 234 |
| DSC1 | 233 |
| IGF2R | 231 |
| TUBB4B | 230 |
| DBNL | 224 |
| PTPRC | 213 |
| KRT1 | 181 |
| PRDX6 | 174 |
| NME2 | 172 |
| LTA4H | 170 |
| ARPC5 | 167 |
| SERPINA1 | 158 |
| LRG1 | 153 |
| TUBB | 148 |
| FCN1 | 145 |
| ANPEP | 140 |
| PRG2 | 132 |
| CD14 | 130 |
| CRISP3 | 114 |
| RAB6A | 110 |
| CFP | 109 |
| PSMA5 | 108 |
| ACTR2 | 107 |
| VAT1 | 102 |
| CTSH | 99 |
| CTSC | 72 |
| ALDOA | 69 |
| FUCA2 | 62 |
| ERP44 | 61 |
| SIRPA | 54 |
| ITGB2 | 49 |
| HSPA8 | 36 |
| RAB7A | 23 |
| FABP5 | 17 |
| A1BG | 16 |
| PFKL | 6 |
| LCN2 | 5 |
| FLG2 | 0 |
| PA2G4 | -3 |
| PKM | -6 |
| TTR | -7 |
| VCL | -11 |
| FTL | -34 |
| ALDOC | -38 |
| CD93 | -41 |
| HSPA1A | -55 |
| SELL | -64 |
| FUCA1 | -68 |
| SNAP23 | -71 |
| DYNC1H1 | -73 |
| VCP | -83 |
| PYGL | -87 |
| PGAM1 | -100 |
| C3 | -102 |
| HSP90AA1 | -123 |
| HLA-C | -127 |
| GDI2 | -139 |
| VNN1 | -146 |
| SLPI | -153 |
| PPIA | -155 |
| CAP1 | -158 |
| FTH1 | -159 |
| S100A7 | -190 |
| BIN2 | -192 |
| STOM | -208 |
| PYGB | -211 |
| GSN | -215 |
| SERPINB1 | -216 |
| CCT2 | -221 |
| HEXB | -224 |
| FCER1G | -242 |
| COTL1 | -253 |
| PPBP | -255 |
| GSTP1 | -266 |
| HSP90AB1 | -271 |
| EEF1A1 | -273 |
| ANO6 | -287 |
| ACLY | -291 |
| CALML5 | -292 |
| PECAM1 | -307 |
| AGA | -308 |
| CNN2 | -312 |
| RAB14 | -316 |
| CYB5R3 | -322 |
| ARG1 | -343 |
| ANXA2 | -345 |
| HLA-B | -358 |
| PSMB7 | -368 |
| S100A8 | -370 |
| CCT8 | -379 |
| S100A9 | -380 |
| ADAM10 | -387 |
| CTSB | -391 |
| RNASE2 | -400 |
| set | Mitochondrial protein degradation |
| setSize | 6 |
| pANOVA | 0.00918 |
| s.dist | -0.616 |
| p.adjustANOVA | 0.553 |
| GeneID | Gene Rank |
|---|---|
| HSPD1 | -398 |
| IDH2 | -374 |
| ATP5F1B | -341 |
| ATP5F1A | -237 |
| ACO2 | -104 |
| APP | 68 |
| GeneID | Gene Rank |
|---|---|
| HSPD1 | -398 |
| IDH2 | -374 |
| ATP5F1B | -341 |
| ATP5F1A | -237 |
| ACO2 | -104 |
| APP | 68 |
| set | EPHA-mediated growth cone collapse |
| setSize | 7 |
| pANOVA | 0.011 |
| s.dist | -0.557 |
| p.adjustANOVA | 0.603 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| MYL9 | -277 |
| SRC | -270 |
| ROCK2 | -256 |
| MYL6 | -156 |
| MYH9 | -97 |
| MYL12B | -4 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| MYL9 | -277 |
| SRC | -270 |
| ROCK2 | -256 |
| MYL6 | -156 |
| MYH9 | -97 |
| MYL12B | -4 |
| set | Cellular responses to stimuli |
| setSize | 86 |
| pANOVA | 0.0123 |
| s.dist | -0.164 |
| p.adjustANOVA | 0.616 |
| GeneID | Gene Rank |
|---|---|
| HSPD1 | -398 |
| GPX1 | -393 |
| CAPZA1 | -390 |
| APOA1 | -385 |
| FYN | -369 |
| PSMB7 | -368 |
| ALB | -366 |
| NOTCH1 | -365 |
| TUBA8 | -364 |
| PRDX5 | -363 |
| PDIA5 | -357 |
| ANXA2 | -345 |
| PSMB3 | -331 |
| PRDX1 | -329 |
| PECAM1 | -307 |
| STIP1 | -275 |
| EEF1A1 | -273 |
| GSR | -272 |
| HSP90AB1 | -271 |
| PRDX3 | -269 |
| GeneID | Gene Rank |
|---|---|
| HSPD1 | -398 |
| GPX1 | -393 |
| CAPZA1 | -390 |
| APOA1 | -385 |
| FYN | -369 |
| PSMB7 | -368 |
| ALB | -366 |
| NOTCH1 | -365 |
| TUBA8 | -364 |
| PRDX5 | -363 |
| PDIA5 | -357 |
| ANXA2 | -345 |
| PSMB3 | -331 |
| PRDX1 | -329 |
| PECAM1 | -307 |
| STIP1 | -275 |
| EEF1A1 | -273 |
| GSR | -272 |
| HSP90AB1 | -271 |
| PRDX3 | -269 |
| GSTP1 | -266 |
| PSMB2 | -265 |
| HSPA4 | -264 |
| FLT4 | -261 |
| ITGB1 | -258 |
| APOB | -240 |
| PGD | -235 |
| GPX3 | -230 |
| GNB2 | -223 |
| PSMA6 | -205 |
| TKT | -196 |
| CALM1 | -169 |
| HSPB1 | -168 |
| PSMA1 | -142 |
| CAPNS1 | -137 |
| HSP90AA1 | -123 |
| CSRP1 | -121 |
| ITGB3 | -98 |
| TLN1 | -86 |
| VCP | -83 |
| HSP90B1 | -77 |
| DYNC1H1 | -73 |
| TUBA4A | -57 |
| HSPA1A | -55 |
| EXTL2 | -47 |
| HSPA5 | -45 |
| HYOU1 | -37 |
| G6PD | -29 |
| FN1 | -25 |
| HSPG2 | -15 |
| VCL | -11 |
| TALDO1 | -2 |
| TUBB1 | 22 |
| CDH5 | 27 |
| HSPA8 | 36 |
| CALR | 64 |
| TXN | 71 |
| PDIA6 | 76 |
| P4HB | 104 |
| PSMA5 | 108 |
| YWHAE | 115 |
| PSMA7 | 129 |
| HSPE1 | 152 |
| PSMA4 | 171 |
| PRDX6 | 174 |
| TUBB4B | 230 |
| HBB | 286 |
| RPS27A | 305 |
| ST13 | 306 |
| SOD3 | 319 |
| SOD2 | 331 |
| PRKAR1A | 335 |
| DPP3 | 338 |
| BLVRB | 341 |
| PRDX2 | 362 |
| PSMD2 | 363 |
| GNAQ | 366 |
| IDH1 | 381 |
| GNB1 | 418 |
| SOD1 | 434 |
| CACNA2D1 | 455 |
| CAT | 456 |
| ACTR1A | 461 |
| PSMD3 | 473 |
| TUBA1C | 478 |
| MAPK1 | 497 |
| set | Innate Immune System |
| setSize | 277 |
| pANOVA | 0.0171 |
| s.dist | 0.0993 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 497 |
| CFHR2 | 489 |
| PRCP | 486 |
| CTSZ | 481 |
| GM2A | 479 |
| HP | 476 |
| ELANE | 475 |
| PSMD3 | 473 |
| RAP1B | 472 |
| GPI | 469 |
| B4GALT1 | 468 |
| CSTB | 467 |
| MLEC | 466 |
| PKP1 | 465 |
| LILRA3 | 464 |
| IGLV7-43 | 463 |
| DIAPH1 | 460 |
| CAT | 456 |
| CFHR4 | 454 |
| IGHV1-46 | 446 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 497 |
| CFHR2 | 489 |
| PRCP | 486 |
| CTSZ | 481 |
| GM2A | 479 |
| HP | 476 |
| ELANE | 475 |
| PSMD3 | 473 |
| RAP1B | 472 |
| GPI | 469 |
| B4GALT1 | 468 |
| CSTB | 467 |
| MLEC | 466 |
| PKP1 | 465 |
| LILRA3 | 464 |
| IGLV7-43 | 463 |
| DIAPH1 | 460 |
| CAT | 456 |
| CFHR4 | 454 |
| IGHV1-46 | 446 |
| CFHR1 | 439 |
| CHI3L1 | 437 |
| RAB10 | 430 |
| IGLV3-19 | 427 |
| LAMP2 | 426 |
| OSCAR | 423 |
| CFL1 | 416 |
| IGLV2-8 | 406 |
| FGL2 | 405 |
| ADA2 | 401 |
| AHSG | 400 |
| CD44 | 398 |
| TXNDC5 | 396 |
| PIGR | 390 |
| PGM1 | 387 |
| IGLV4-69 | 385 |
| IQGAP2 | 383 |
| IDH1 | 381 |
| CAMP | 380 |
| SERPINB12 | 378 |
| B2M | 376 |
| IGHV3-48 | 371 |
| GRB2 | 368 |
| COLEC10 | 364 |
| PSMD2 | 363 |
| CPN1 | 359 |
| CST3 | 357 |
| MASP2 | 356 |
| PRKCSH | 355 |
| LYZ | 353 |
| FGB | 343 |
| GRN | 342 |
| CFH | 340 |
| GGH | 337 |
| IGLV8-61 | 336 |
| HRNR | 326 |
| LGALS3 | 322 |
| DSP | 321 |
| C4BPA | 318 |
| C2 | 317 |
| CFD | 315 |
| SERPINA3 | 311 |
| CAPN1 | 310 |
| IGLV1-44 | 308 |
| PRSS3 | 307 |
| RPS27A | 305 |
| DSG1 | 303 |
| JUP | 302 |
| IGLV1-40 | 300 |
| PTPRJ | 299 |
| FGA | 297 |
| C4BPB | 292 |
| CTSS | 289 |
| HBB | 286 |
| IGHV3-13 | 285 |
| CPB2 | 282 |
| CFB | 277 |
| ORM1 | 276 |
| ALAD | 275 |
| PNP | 267 |
| BST1 | 262 |
| MMP9 | 260 |
| LTF | 257 |
| CTSD | 252 |
| TIMP2 | 247 |
| C9 | 244 |
| QSOX1 | 238 |
| ORM2 | 234 |
| DSC1 | 233 |
| IGF2R | 231 |
| TUBB4B | 230 |
| DBNL | 224 |
| FGG | 219 |
| COLEC11 | 215 |
| PTPRC | 213 |
| C1QC | 211 |
| IGHV3-7 | 205 |
| CRP | 201 |
| MASP1 | 199 |
| CFHR5 | 197 |
| MBL2 | 191 |
| C6 | 190 |
| SAA1 | 188 |
| IGHV3-23 | 186 |
| SERPING1 | 184 |
| IGHE | 182 |
| KRT1 | 181 |
| PRDX6 | 174 |
| NME2 | 172 |
| PSMA4 | 171 |
| LTA4H | 170 |
| ARPC5 | 167 |
| C1QA | 161 |
| SERPINA1 | 158 |
| LRG1 | 153 |
| TUBB | 148 |
| IGHV4-34 | 146 |
| FCN1 | 145 |
| IGLV6-57 | 144 |
| ANPEP | 140 |
| FCN3 | 136 |
| IGLV4-3 | 134 |
| PRG2 | 132 |
| IGHV1-69 | 131 |
| CD14 | 130 |
| PSMA7 | 129 |
| C8G | 127 |
| IGLV2-11 | 122 |
| C4B | 117 |
| IGLV2-14 | 116 |
| CRISP3 | 114 |
| IGKV3-11 | 113 |
| IGKV1D-33 | 111 |
| RAB6A | 110 |
| CFP | 109 |
| PSMA5 | 108 |
| ACTR2 | 107 |
| VAT1 | 102 |
| CTSH | 99 |
| C7 | 88 |
| UBE2V1 | 85 |
| LBP | 82 |
| IGLC7 | 81 |
| IGKV4-1 | 80 |
| C8B | 78 |
| CFI | 75 |
| CTSC | 72 |
| TXN | 71 |
| ALDOA | 69 |
| APP | 68 |
| IGHG3 | 65 |
| PROS1 | 63 |
| FUCA2 | 62 |
| ERP44 | 61 |
| FCGR3A | 60 |
| C1S | 56 |
| SYK | 55 |
| SIRPA | 54 |
| IGLV1-47 | 53 |
| ITGB2 | 49 |
| C5 | 48 |
| FCN2 | 45 |
| C8A | 44 |
| IGLV1-36 | 40 |
| HSPA8 | 36 |
| IGLV1-51 | 29 |
| RAB7A | 23 |
| FABP5 | 17 |
| A1BG | 16 |
| PFKL | 6 |
| LCN2 | 5 |
| FLG2 | 0 |
| PA2G4 | -3 |
| PKM | -6 |
| TTR | -7 |
| IGHV2-70 | -10 |
| VCL | -11 |
| C1R | -16 |
| C1QB | -24 |
| VTN | -26 |
| BPIFB1 | -27 |
| FTL | -34 |
| ALDOC | -38 |
| CD93 | -41 |
| IGHV3-30 | -46 |
| ACTR3 | -54 |
| HSPA1A | -55 |
| SELL | -64 |
| CLU | -65 |
| FUCA1 | -68 |
| SNAP23 | -71 |
| ARPC3 | -72 |
| DYNC1H1 | -73 |
| HSP90B1 | -77 |
| PGLYRP2 | -79 |
| CPN2 | -81 |
| VCP | -83 |
| IGHG2 | -85 |
| PYGL | -87 |
| IGHV2-5 | -94 |
| MYH9 | -97 |
| PGAM1 | -100 |
| C3 | -102 |
| ACTB | -109 |
| HSP90AA1 | -123 |
| HLA-C | -127 |
| GDI2 | -139 |
| PSMA1 | -142 |
| IGKV1-17 | -143 |
| VNN1 | -146 |
| SLPI | -153 |
| PPIA | -155 |
| CAP1 | -158 |
| FTH1 | -159 |
| IGHV3-9 | -165 |
| IGLV2-18 | -167 |
| CALM1 | -169 |
| ARPC2 | -171 |
| F2 | -177 |
| IGHG4 | -185 |
| IGHV1-2 | -186 |
| S100A7 | -190 |
| BIN2 | -192 |
| PSMA6 | -205 |
| STOM | -208 |
| IGKV1-16 | -209 |
| PYGB | -211 |
| GSN | -215 |
| SERPINB1 | -216 |
| CCT2 | -221 |
| HEXB | -224 |
| ARPC1B | -228 |
| APOB | -240 |
| FCER1G | -242 |
| IGLC2 | -244 |
| COTL1 | -253 |
| PPBP | -255 |
| IGKV1-5 | -260 |
| IGKV3D-20 | -262 |
| CHGA | -263 |
| PSMB2 | -265 |
| GSTP1 | -266 |
| SRC | -270 |
| HSP90AB1 | -271 |
| EEF1A1 | -273 |
| IGLV3-16 | -282 |
| IGKC | -284 |
| IGLV4-60 | -285 |
| ANO6 | -287 |
| IGLV2-23 | -290 |
| ACLY | -291 |
| CALML5 | -292 |
| ITLN1 | -302 |
| PECAM1 | -307 |
| AGA | -308 |
| CNN2 | -312 |
| RAB14 | -316 |
| C4A | -319 |
| CYB5R3 | -322 |
| PSMB3 | -331 |
| IGKV3-20 | -333 |
| IGHG1 | -337 |
| ARG1 | -343 |
| ANXA2 | -345 |
| IGKV1D-16 | -348 |
| HLA-B | -358 |
| PSMB7 | -368 |
| FYN | -369 |
| S100A8 | -370 |
| CCT8 | -379 |
| S100A9 | -380 |
| ADAM10 | -387 |
| CAPZA1 | -390 |
| CTSB | -391 |
| RNASE2 | -400 |
| RASGRP2 | -402 |
| ARPC4 | -403 |
| set | Diseases of carbohydrate metabolism |
| setSize | 6 |
| pANOVA | 0.0185 |
| s.dist | 0.557 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| DCXR | 442 |
| HYAL1 | 410 |
| ALDOB | 339 |
| RPS27A | 305 |
| NAGLU | 280 |
| TALDO1 | -2 |
| GeneID | Gene Rank |
|---|---|
| DCXR | 442 |
| HYAL1 | 410 |
| ALDOB | 339 |
| RPS27A | 305 |
| NAGLU | 280 |
| TALDO1 | -2 |
| set | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function |
| setSize | 5 |
| pANOVA | 0.02 |
| s.dist | -0.602 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| GP1BA | -346 |
| MYL9 | -277 |
| PF4 | -252 |
| THBS1 | -199 |
| ITGA2B | -52 |
| GeneID | Gene Rank |
|---|---|
| GP1BA | -346 |
| MYL9 | -277 |
| PF4 | -252 |
| THBS1 | -199 |
| ITGA2B | -52 |
| set | RHOBTB GTPase Cycle |
| setSize | 8 |
| pANOVA | 0.0205 |
| s.dist | -0.475 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| CCT6A | -339 |
| HSP90AB1 | -271 |
| ROCK2 | -256 |
| CCT2 | -221 |
| HSP90AA1 | -123 |
| ACTN1 | -96 |
| TXNL1 | 367 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| CCT6A | -339 |
| HSP90AB1 | -271 |
| ROCK2 | -256 |
| CCT2 | -221 |
| HSP90AA1 | -123 |
| ACTN1 | -96 |
| TXNL1 | 367 |
| set | Signaling by Rho GTPases |
| setSize | 70 |
| pANOVA | 0.0245 |
| s.dist | -0.162 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| DBN1 | -399 |
| TPM3 | -394 |
| S100A9 | -380 |
| S100A8 | -370 |
| TUBA8 | -364 |
| CCT6A | -339 |
| FLOT2 | -326 |
| YWHAG | -325 |
| ARHGDIB | -305 |
| MYL9 | -277 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| BCAP31 | -233 |
| ARPC1B | -228 |
| CCT2 | -221 |
| STOM | -208 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| DBN1 | -399 |
| TPM3 | -394 |
| S100A9 | -380 |
| S100A8 | -370 |
| TUBA8 | -364 |
| CCT6A | -339 |
| FLOT2 | -326 |
| YWHAG | -325 |
| ARHGDIB | -305 |
| MYL9 | -277 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| BCAP31 | -233 |
| ARPC1B | -228 |
| CCT2 | -221 |
| STOM | -208 |
| TPM4 | -178 |
| ARPC2 | -171 |
| CALM1 | -169 |
| MYL6 | -156 |
| CTTN | -150 |
| PFN1 | -148 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| BASP1 | -103 |
| MYH9 | -97 |
| ACTN1 | -96 |
| VCP | -83 |
| PLXNB1 | -80 |
| DYNC1H1 | -73 |
| ARPC3 | -72 |
| SNAP23 | -71 |
| AKAP12 | -70 |
| TUBA4A | -57 |
| ACTR3 | -54 |
| TFRC | -53 |
| FLNA | -51 |
| DSG2 | -49 |
| MYL12B | -4 |
| YWHAZ | 3 |
| ACTC1 | 4 |
| TUBB1 | 22 |
| RAB7A | 23 |
| MCAM | 37 |
| YWHAB | 58 |
| ACTR2 | 107 |
| YWHAE | 115 |
| HSPE1 | 152 |
| ARPC5 | 167 |
| CLTC | 178 |
| CDH1 | 206 |
| TUBB4B | 230 |
| JUP | 302 |
| DSG1 | 303 |
| RHOC | 314 |
| DSP | 321 |
| TXNL1 | 367 |
| GRB2 | 368 |
| IQGAP2 | 383 |
| ARHGAP1 | 397 |
| CFL1 | 416 |
| YWHAH | 431 |
| KIF2A | 449 |
| DIAPH1 | 460 |
| TUBA1C | 478 |
| MAPK1 | 497 |
| set | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
| setSize | 70 |
| pANOVA | 0.0245 |
| s.dist | -0.162 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| DBN1 | -399 |
| TPM3 | -394 |
| S100A9 | -380 |
| S100A8 | -370 |
| TUBA8 | -364 |
| CCT6A | -339 |
| FLOT2 | -326 |
| YWHAG | -325 |
| ARHGDIB | -305 |
| MYL9 | -277 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| BCAP31 | -233 |
| ARPC1B | -228 |
| CCT2 | -221 |
| STOM | -208 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| DBN1 | -399 |
| TPM3 | -394 |
| S100A9 | -380 |
| S100A8 | -370 |
| TUBA8 | -364 |
| CCT6A | -339 |
| FLOT2 | -326 |
| YWHAG | -325 |
| ARHGDIB | -305 |
| MYL9 | -277 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| BCAP31 | -233 |
| ARPC1B | -228 |
| CCT2 | -221 |
| STOM | -208 |
| TPM4 | -178 |
| ARPC2 | -171 |
| CALM1 | -169 |
| MYL6 | -156 |
| CTTN | -150 |
| PFN1 | -148 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| BASP1 | -103 |
| MYH9 | -97 |
| ACTN1 | -96 |
| VCP | -83 |
| PLXNB1 | -80 |
| DYNC1H1 | -73 |
| ARPC3 | -72 |
| SNAP23 | -71 |
| AKAP12 | -70 |
| TUBA4A | -57 |
| ACTR3 | -54 |
| TFRC | -53 |
| FLNA | -51 |
| DSG2 | -49 |
| MYL12B | -4 |
| YWHAZ | 3 |
| ACTC1 | 4 |
| TUBB1 | 22 |
| RAB7A | 23 |
| MCAM | 37 |
| YWHAB | 58 |
| ACTR2 | 107 |
| YWHAE | 115 |
| HSPE1 | 152 |
| ARPC5 | 167 |
| CLTC | 178 |
| CDH1 | 206 |
| TUBB4B | 230 |
| JUP | 302 |
| DSG1 | 303 |
| RHOC | 314 |
| DSP | 321 |
| TXNL1 | 367 |
| GRB2 | 368 |
| IQGAP2 | 383 |
| ARHGAP1 | 397 |
| CFL1 | 416 |
| YWHAH | 431 |
| KIF2A | 449 |
| DIAPH1 | 460 |
| TUBA1C | 478 |
| MAPK1 | 497 |
| set | Muscle contraction |
| setSize | 16 |
| pANOVA | 0.027 |
| s.dist | -0.322 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| TPM3 | -394 |
| ANXA2 | -345 |
| MYL9 | -277 |
| TTN | -181 |
| TPM4 | -178 |
| CALM1 | -169 |
| MYL6 | -156 |
| ATP2A3 | -117 |
| CES1 | -112 |
| TLN1 | -86 |
| CALD1 | -18 |
| VCL | -11 |
| MYL12B | -4 |
| ACTC1 | 4 |
| ANXA1 | 46 |
| TPM1 | 438 |
| GeneID | Gene Rank |
|---|---|
| TPM3 | -394 |
| ANXA2 | -345 |
| MYL9 | -277 |
| TTN | -181 |
| TPM4 | -178 |
| CALM1 | -169 |
| MYL6 | -156 |
| ATP2A3 | -117 |
| CES1 | -112 |
| TLN1 | -86 |
| CALD1 | -18 |
| VCL | -11 |
| MYL12B | -4 |
| ACTC1 | 4 |
| ANXA1 | 46 |
| TPM1 | 438 |
| set | EPH-Ephrin signaling |
| setSize | 20 |
| pANOVA | 0.0276 |
| s.dist | -0.288 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| ADAM10 | -387 |
| FYN | -369 |
| MYL9 | -277 |
| SRC | -270 |
| ROCK2 | -256 |
| ARPC1B | -228 |
| ARPC2 | -171 |
| MYL6 | -156 |
| ACTB | -109 |
| MYH9 | -97 |
| ARPC3 | -72 |
| ACTR3 | -54 |
| MYL12B | -4 |
| MMP2 | 92 |
| ACTR2 | 107 |
| ARPC5 | 167 |
| CLTC | 178 |
| MMP9 | 260 |
| CFL1 | 416 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| ADAM10 | -387 |
| FYN | -369 |
| MYL9 | -277 |
| SRC | -270 |
| ROCK2 | -256 |
| ARPC1B | -228 |
| ARPC2 | -171 |
| MYL6 | -156 |
| ACTB | -109 |
| MYH9 | -97 |
| ARPC3 | -72 |
| ACTR3 | -54 |
| MYL12B | -4 |
| MMP2 | 92 |
| ACTR2 | 107 |
| ARPC5 | 167 |
| CLTC | 178 |
| MMP9 | 260 |
| CFL1 | 416 |
| set | Scavenging by Class B Receptors |
| setSize | 7 |
| pANOVA | 0.0284 |
| s.dist | -0.48 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| APOA1 | -385 |
| S100A9 | -380 |
| PRDX1 | -329 |
| APOB | -240 |
| CD5L | -182 |
| SSC5D | 139 |
| SAA1 | 188 |
| GeneID | Gene Rank |
|---|---|
| APOA1 | -385 |
| S100A9 | -380 |
| PRDX1 | -329 |
| APOB | -240 |
| CD5L | -182 |
| SSC5D | 139 |
| SAA1 | 188 |
| set | Lysosome Vesicle Biogenesis |
| setSize | 6 |
| pANOVA | 0.0301 |
| s.dist | 0.513 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| ARRB1 | 496 |
| CTSZ | 481 |
| TXNDC5 | 396 |
| CLTC | 178 |
| APP | 68 |
| HSPA8 | 36 |
| GeneID | Gene Rank |
|---|---|
| ARRB1 | 496 |
| CTSZ | 481 |
| TXNDC5 | 396 |
| CLTC | 178 |
| APP | 68 |
| HSPA8 | 36 |
| set | Folding of actin by CCT/TriC |
| setSize | 6 |
| pANOVA | 0.0303 |
| s.dist | -0.512 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| CCT8 | -379 |
| CCT6A | -339 |
| CCT2 | -221 |
| CCT5 | -201 |
| ACTB | -109 |
| TCP1 | 142 |
| GeneID | Gene Rank |
|---|---|
| CCT8 | -379 |
| CCT6A | -339 |
| CCT2 | -221 |
| CCT5 | -201 |
| ACTB | -109 |
| TCP1 | 142 |
| set | Association of TriC/CCT with target proteins during biosynthesis |
| setSize | 6 |
| pANOVA | 0.0326 |
| s.dist | -0.506 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| CCT8 | -379 |
| CCT6A | -339 |
| CCT2 | -221 |
| CCT5 | -201 |
| GBA1 | -91 |
| TCP1 | 142 |
| GeneID | Gene Rank |
|---|---|
| CCT8 | -379 |
| CCT6A | -339 |
| CCT2 | -221 |
| CCT5 | -201 |
| GBA1 | -91 |
| TCP1 | 142 |
| set | Sensory processing of sound |
| setSize | 5 |
| pANOVA | 0.0329 |
| s.dist | -0.552 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| CAPZA1 | -390 |
| GSN | -215 |
| MSN | -203 |
| ACTB | -109 |
| MYH9 | -97 |
| GeneID | Gene Rank |
|---|---|
| CAPZA1 | -390 |
| GSN | -215 |
| MSN | -203 |
| ACTB | -109 |
| MYH9 | -97 |
| set | Phospholipid metabolism |
| setSize | 5 |
| pANOVA | 0.0346 |
| s.dist | -0.547 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| MGLL | -350 |
| PIP4K2A | -320 |
| RAB14 | -316 |
| ARF3 | -279 |
| BCHE | 263 |
| GeneID | Gene Rank |
|---|---|
| MGLL | -350 |
| PIP4K2A | -320 |
| RAB14 | -316 |
| ARF3 | -279 |
| BCHE | 263 |
| set | Mitochondrial biogenesis |
| setSize | 6 |
| pANOVA | 0.0356 |
| s.dist | -0.497 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| IDH2 | -374 |
| ATP5F1B | -341 |
| ATP5PB | -276 |
| ATP5F1A | -237 |
| CALM1 | -169 |
| SOD2 | 331 |
| GeneID | Gene Rank |
|---|---|
| IDH2 | -374 |
| ATP5F1B | -341 |
| ATP5PB | -276 |
| ATP5F1A | -237 |
| CALM1 | -169 |
| SOD2 | 331 |
| set | Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| setSize | 10 |
| pANOVA | 0.0358 |
| s.dist | -0.385 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| HLA-A | -392 |
| HLA-B | -358 |
| CANX | -352 |
| BCAP31 | -233 |
| ERAP2 | -180 |
| HLA-C | -127 |
| HSPA5 | -45 |
| PDIA3 | -21 |
| CALR | 64 |
| B2M | 376 |
| GeneID | Gene Rank |
|---|---|
| HLA-A | -392 |
| HLA-B | -358 |
| CANX | -352 |
| BCAP31 | -233 |
| ERAP2 | -180 |
| HLA-C | -127 |
| HSPA5 | -45 |
| PDIA3 | -21 |
| CALR | 64 |
| B2M | 376 |
| set | MET activates PTK2 signaling |
| setSize | 8 |
| pANOVA | 0.0393 |
| s.dist | -0.423 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| ITGA2 | -361 |
| LAMC1 | -356 |
| SRC | -270 |
| ITGB1 | -258 |
| FN1 | -25 |
| LAMB1 | 28 |
| LAMA2 | 34 |
| MET | 57 |
| GeneID | Gene Rank |
|---|---|
| ITGA2 | -361 |
| LAMC1 | -356 |
| SRC | -270 |
| ITGB1 | -258 |
| FN1 | -25 |
| LAMB1 | 28 |
| LAMA2 | 34 |
| MET | 57 |
| set | Signal Transduction |
| setSize | 187 |
| pANOVA | 0.0395 |
| s.dist | -0.0976 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| VPS29 | -404 |
| ARPC4 | -403 |
| RASGRP2 | -402 |
| DBN1 | -399 |
| TPM3 | -394 |
| ADAM10 | -387 |
| HGFAC | -383 |
| IHH | -382 |
| CILP | -381 |
| S100A9 | -380 |
| S100A8 | -370 |
| FYN | -369 |
| PSMB7 | -368 |
| NOTCH1 | -365 |
| TUBA8 | -364 |
| ITGA2 | -361 |
| LAMC1 | -356 |
| MGLL | -350 |
| GNAI2 | -340 |
| CCT6A | -339 |
| GeneID | Gene Rank |
|---|---|
| VPS29 | -404 |
| ARPC4 | -403 |
| RASGRP2 | -402 |
| DBN1 | -399 |
| TPM3 | -394 |
| ADAM10 | -387 |
| HGFAC | -383 |
| IHH | -382 |
| CILP | -381 |
| S100A9 | -380 |
| S100A8 | -370 |
| FYN | -369 |
| PSMB7 | -368 |
| NOTCH1 | -365 |
| TUBA8 | -364 |
| ITGA2 | -361 |
| LAMC1 | -356 |
| MGLL | -350 |
| GNAI2 | -340 |
| CCT6A | -339 |
| TIMP1 | -336 |
| PSMB3 | -331 |
| FLOT2 | -326 |
| YWHAG | -325 |
| PIP4K2A | -320 |
| ARHGDIB | -305 |
| GPNMB | -297 |
| MYL9 | -277 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| PSMB2 | -265 |
| FLT4 | -261 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| PPBP | -255 |
| PF4 | -252 |
| FGFBP2 | -238 |
| BCAP31 | -233 |
| EGFR | -232 |
| NOTCH2 | -231 |
| ARPC1B | -228 |
| TGFB1 | -225 |
| GNB2 | -223 |
| CCT2 | -221 |
| LTBP1 | -219 |
| STOM | -208 |
| PSMA6 | -205 |
| THBS1 | -199 |
| TPM4 | -178 |
| F2 | -177 |
| ARPC2 | -171 |
| SPARC | -170 |
| CALM1 | -169 |
| HSPB1 | -168 |
| MYL6 | -156 |
| CTTN | -150 |
| FKBP1A | -149 |
| PFN1 | -148 |
| PSMA1 | -142 |
| STRAP | -136 |
| PLG | -135 |
| CDK5R2 | -125 |
| HSP90AA1 | -123 |
| ATP2A3 | -117 |
| ANGPTL3 | -116 |
| LYPLA1 | -114 |
| PPP1CA | -113 |
| ACTB | -109 |
| BASP1 | -103 |
| C3 | -102 |
| ITGB3 | -98 |
| MYH9 | -97 |
| ACTN1 | -96 |
| NOTCH3 | -93 |
| TLN1 | -86 |
| VCP | -83 |
| PLXNB1 | -80 |
| CETP | -75 |
| DYNC1H1 | -73 |
| ARPC3 | -72 |
| SNAP23 | -71 |
| AKAP12 | -70 |
| COL6A1 | -59 |
| TUBA4A | -57 |
| ACTR3 | -54 |
| TFRC | -53 |
| ITGA2B | -52 |
| FLNA | -51 |
| DSG2 | -49 |
| FN1 | -25 |
| F11R | -22 |
| PLTP | -17 |
| VCL | -11 |
| MYL12B | -4 |
| APOD | 2 |
| YWHAZ | 3 |
| ACTC1 | 4 |
| IL6R | 10 |
| FABP5 | 17 |
| TUBB1 | 22 |
| RAB7A | 23 |
| CDH5 | 27 |
| LAMB1 | 28 |
| APOC1 | 33 |
| LAMA2 | 34 |
| MCAM | 37 |
| NCAM1 | 43 |
| ANXA1 | 46 |
| C5 | 48 |
| SYK | 55 |
| MET | 57 |
| YWHAB | 58 |
| APP | 68 |
| APOE | 84 |
| IL1RAP | 86 |
| MMP2 | 92 |
| CNTN1 | 93 |
| KIT | 103 |
| P4HB | 104 |
| ACTR2 | 107 |
| PSMA5 | 108 |
| RAB6A | 110 |
| YWHAE | 115 |
| PTPRF | 118 |
| ADH4 | 123 |
| PSMA7 | 129 |
| VWF | 133 |
| HSPE1 | 152 |
| FBN1 | 163 |
| ARPC5 | 167 |
| PSMA4 | 171 |
| CLTC | 178 |
| NRP2 | 179 |
| SAA1 | 188 |
| CDH1 | 206 |
| PEBP1 | 210 |
| COL6A3 | 216 |
| THBS4 | 218 |
| FGG | 219 |
| SERPINE1 | 220 |
| TUBB4B | 230 |
| TIMP2 | 247 |
| MST1 | 248 |
| IGF2 | 251 |
| CTSD | 252 |
| NRP1 | 255 |
| MMP9 | 260 |
| CCL5 | 284 |
| FGA | 297 |
| PTPRJ | 299 |
| JUP | 302 |
| DSG1 | 303 |
| RPS27A | 305 |
| RHOC | 314 |
| APOC2 | 316 |
| DSP | 321 |
| KNG1 | 332 |
| PRKAR1A | 335 |
| FGB | 343 |
| AGT | 346 |
| PSMD2 | 363 |
| GNAQ | 366 |
| TXNL1 | 367 |
| GRB2 | 368 |
| APOC4 | 373 |
| SPTA1 | 374 |
| COL4A1 | 377 |
| SHH | 379 |
| IQGAP2 | 383 |
| SPTB | 391 |
| ARHGAP1 | 397 |
| CFL1 | 416 |
| GNB1 | 418 |
| ALDH1A1 | 429 |
| YWHAH | 431 |
| KIF2A | 449 |
| DIAPH1 | 460 |
| B4GALT1 | 468 |
| RAP1B | 472 |
| PSMD3 | 473 |
| ELANE | 475 |
| TUBA1C | 478 |
| FSTL1 | 484 |
| IGF1 | 491 |
| ARRB1 | 496 |
| MAPK1 | 497 |
| set | VEGFA-VEGFR2 Pathway |
| setSize | 10 |
| pANOVA | 0.0397 |
| s.dist | -0.378 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| SRC | -270 |
| ROCK2 | -256 |
| CALM1 | -169 |
| HSPB1 | -168 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| ITGB3 | -98 |
| CDH5 | 27 |
| JUP | 302 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| SRC | -270 |
| ROCK2 | -256 |
| CALM1 | -169 |
| HSPB1 | -168 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| ITGB3 | -98 |
| CDH5 | 27 |
| JUP | 302 |
| set | Fatty acid metabolism |
| setSize | 11 |
| pANOVA | 0.0398 |
| s.dist | -0.36 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| GPX1 | -393 |
| DECR1 | -362 |
| PON1 | -335 |
| ACLY | -291 |
| TBXAS1 | -161 |
| PTGS1 | -132 |
| DPEP2 | -44 |
| PON3 | 11 |
| EPHX2 | 19 |
| LTA4H | 170 |
| PTGDS | 250 |
| GeneID | Gene Rank |
|---|---|
| GPX1 | -393 |
| DECR1 | -362 |
| PON1 | -335 |
| ACLY | -291 |
| TBXAS1 | -161 |
| PTGS1 | -132 |
| DPEP2 | -44 |
| PON3 | 11 |
| EPHX2 | 19 |
| LTA4H | 170 |
| PTGDS | 250 |
| set | RHOBTB2 GTPase cycle |
| setSize | 7 |
| pANOVA | 0.0418 |
| s.dist | -0.446 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| CCT6A | -339 |
| HSP90AB1 | -271 |
| CCT2 | -221 |
| HSP90AA1 | -123 |
| ACTN1 | -96 |
| TXNL1 | 367 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| CCT6A | -339 |
| HSP90AB1 | -271 |
| CCT2 | -221 |
| HSP90AA1 | -123 |
| ACTN1 | -96 |
| TXNL1 | 367 |
| set | Cellular responses to stress |
| setSize | 68 |
| pANOVA | 0.0422 |
| s.dist | -0.148 |
| p.adjustANOVA | 0.747 |
| GeneID | Gene Rank |
|---|---|
| HSPD1 | -398 |
| GPX1 | -393 |
| CAPZA1 | -390 |
| APOA1 | -385 |
| PSMB7 | -368 |
| ALB | -366 |
| NOTCH1 | -365 |
| TUBA8 | -364 |
| PRDX5 | -363 |
| PDIA5 | -357 |
| PSMB3 | -331 |
| PRDX1 | -329 |
| STIP1 | -275 |
| EEF1A1 | -273 |
| GSR | -272 |
| HSP90AB1 | -271 |
| PRDX3 | -269 |
| GSTP1 | -266 |
| PSMB2 | -265 |
| HSPA4 | -264 |
| GeneID | Gene Rank |
|---|---|
| HSPD1 | -398 |
| GPX1 | -393 |
| CAPZA1 | -390 |
| APOA1 | -385 |
| PSMB7 | -368 |
| ALB | -366 |
| NOTCH1 | -365 |
| TUBA8 | -364 |
| PRDX5 | -363 |
| PDIA5 | -357 |
| PSMB3 | -331 |
| PRDX1 | -329 |
| STIP1 | -275 |
| EEF1A1 | -273 |
| GSR | -272 |
| HSP90AB1 | -271 |
| PRDX3 | -269 |
| GSTP1 | -266 |
| PSMB2 | -265 |
| HSPA4 | -264 |
| APOB | -240 |
| PGD | -235 |
| GPX3 | -230 |
| PSMA6 | -205 |
| TKT | -196 |
| HSPB1 | -168 |
| PSMA1 | -142 |
| HSP90AA1 | -123 |
| TLN1 | -86 |
| VCP | -83 |
| HSP90B1 | -77 |
| DYNC1H1 | -73 |
| TUBA4A | -57 |
| HSPA1A | -55 |
| EXTL2 | -47 |
| HSPA5 | -45 |
| HYOU1 | -37 |
| G6PD | -29 |
| TALDO1 | -2 |
| TUBB1 | 22 |
| HSPA8 | 36 |
| CALR | 64 |
| TXN | 71 |
| PDIA6 | 76 |
| P4HB | 104 |
| PSMA5 | 108 |
| YWHAE | 115 |
| PSMA7 | 129 |
| HSPE1 | 152 |
| PSMA4 | 171 |
| PRDX6 | 174 |
| TUBB4B | 230 |
| HBB | 286 |
| RPS27A | 305 |
| ST13 | 306 |
| SOD3 | 319 |
| SOD2 | 331 |
| DPP3 | 338 |
| BLVRB | 341 |
| PRDX2 | 362 |
| PSMD2 | 363 |
| IDH1 | 381 |
| SOD1 | 434 |
| CAT | 456 |
| ACTR1A | 461 |
| PSMD3 | 473 |
| TUBA1C | 478 |
| MAPK1 | 497 |
| set | Immune System |
| setSize | 337 |
| pANOVA | 0.0448 |
| s.dist | 0.0797 |
| p.adjustANOVA | 0.757 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 497 |
| CFHR2 | 489 |
| STXBP2 | 488 |
| PRCP | 486 |
| CSF1R | 483 |
| CTSZ | 481 |
| GM2A | 479 |
| TUBA1C | 478 |
| HP | 476 |
| ELANE | 475 |
| PSMD3 | 473 |
| RAP1B | 472 |
| GPI | 469 |
| B4GALT1 | 468 |
| CSTB | 467 |
| MLEC | 466 |
| PKP1 | 465 |
| LILRA3 | 464 |
| IGLV7-43 | 463 |
| ACTR1A | 461 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 497 |
| CFHR2 | 489 |
| STXBP2 | 488 |
| PRCP | 486 |
| CSF1R | 483 |
| CTSZ | 481 |
| GM2A | 479 |
| TUBA1C | 478 |
| HP | 476 |
| ELANE | 475 |
| PSMD3 | 473 |
| RAP1B | 472 |
| GPI | 469 |
| B4GALT1 | 468 |
| CSTB | 467 |
| MLEC | 466 |
| PKP1 | 465 |
| LILRA3 | 464 |
| IGLV7-43 | 463 |
| ACTR1A | 461 |
| DIAPH1 | 460 |
| CAT | 456 |
| CFHR4 | 454 |
| KIF2A | 449 |
| IGHV1-46 | 446 |
| CFHR1 | 439 |
| CHI3L1 | 437 |
| SOD1 | 434 |
| RAB10 | 430 |
| IGLV3-19 | 427 |
| LAMP2 | 426 |
| OSCAR | 423 |
| CFL1 | 416 |
| IGLV2-8 | 406 |
| FGL2 | 405 |
| ADA2 | 401 |
| AHSG | 400 |
| CD44 | 398 |
| TXNDC5 | 396 |
| PIGR | 390 |
| PGM1 | 387 |
| IGLV4-69 | 385 |
| IQGAP2 | 383 |
| IDH1 | 381 |
| CAMP | 380 |
| SERPINB12 | 378 |
| B2M | 376 |
| IGHV3-48 | 371 |
| GRB2 | 368 |
| COLEC10 | 364 |
| PSMD2 | 363 |
| FYB1 | 361 |
| CPN1 | 359 |
| CST3 | 357 |
| MASP2 | 356 |
| PRKCSH | 355 |
| LYZ | 353 |
| FGB | 343 |
| GRN | 342 |
| CFH | 340 |
| GGH | 337 |
| IGLV8-61 | 336 |
| SOD2 | 331 |
| FSCN1 | 327 |
| HRNR | 326 |
| LGALS3 | 322 |
| DSP | 321 |
| C4BPA | 318 |
| C2 | 317 |
| CFD | 315 |
| SERPINA3 | 311 |
| CAPN1 | 310 |
| IGLV1-44 | 308 |
| PRSS3 | 307 |
| RPS27A | 305 |
| DSG1 | 303 |
| JUP | 302 |
| IGLV1-40 | 300 |
| PTPRJ | 299 |
| FGA | 297 |
| ICOSLG | 293 |
| C4BPB | 292 |
| CTSS | 289 |
| HBB | 286 |
| IGHV3-13 | 285 |
| CCL5 | 284 |
| BLMH | 283 |
| CPB2 | 282 |
| CFB | 277 |
| ORM1 | 276 |
| ALAD | 275 |
| UBA1 | 272 |
| PNP | 267 |
| ICAM1 | 266 |
| BST1 | 262 |
| MMP9 | 260 |
| LTF | 257 |
| CTSD | 252 |
| TIMP2 | 247 |
| C9 | 244 |
| CA1 | 240 |
| QSOX1 | 238 |
| ORM2 | 234 |
| DSC1 | 233 |
| IGF2R | 231 |
| TUBB4B | 230 |
| DBNL | 224 |
| FGG | 219 |
| MRC1 | 217 |
| COLEC11 | 215 |
| PTPRC | 213 |
| C1QC | 211 |
| CDH1 | 206 |
| IGHV3-7 | 205 |
| CRP | 201 |
| MASP1 | 199 |
| CFHR5 | 197 |
| MBL2 | 191 |
| C6 | 190 |
| SAA1 | 188 |
| IGHV3-23 | 186 |
| SERPING1 | 184 |
| IGHE | 182 |
| KRT1 | 181 |
| CLTC | 178 |
| PRDX6 | 174 |
| NME2 | 172 |
| PSMA4 | 171 |
| LTA4H | 170 |
| ARPC5 | 167 |
| C1QA | 161 |
| MRC2 | 159 |
| SERPINA1 | 158 |
| LRG1 | 153 |
| TUBB | 148 |
| IGHV4-34 | 146 |
| FCN1 | 145 |
| IGLV6-57 | 144 |
| TCP1 | 142 |
| ANPEP | 140 |
| VCAM1 | 137 |
| FCN3 | 136 |
| IGLV4-3 | 134 |
| PRG2 | 132 |
| IGHV1-69 | 131 |
| CD14 | 130 |
| PSMA7 | 129 |
| C8G | 127 |
| IGLV2-11 | 122 |
| C4B | 117 |
| IGLV2-14 | 116 |
| CRISP3 | 114 |
| IGKV3-11 | 113 |
| IGKV1D-33 | 111 |
| RAB6A | 110 |
| CFP | 109 |
| PSMA5 | 108 |
| ACTR2 | 107 |
| P4HB | 104 |
| VAT1 | 102 |
| CTSH | 99 |
| MMP2 | 92 |
| C7 | 88 |
| IL1RAP | 86 |
| UBE2V1 | 85 |
| LBP | 82 |
| IGLC7 | 81 |
| IGKV4-1 | 80 |
| C8B | 78 |
| CFI | 75 |
| CTSC | 72 |
| TXN | 71 |
| ALDOA | 69 |
| APP | 68 |
| IGHG3 | 65 |
| CALR | 64 |
| PROS1 | 63 |
| FUCA2 | 62 |
| ERP44 | 61 |
| FCGR3A | 60 |
| YWHAB | 58 |
| C1S | 56 |
| SYK | 55 |
| SIRPA | 54 |
| IGLV1-47 | 53 |
| ITGB2 | 49 |
| C5 | 48 |
| ANXA1 | 46 |
| FCN2 | 45 |
| C8A | 44 |
| NCAM1 | 43 |
| IGLV1-36 | 40 |
| HSPA8 | 36 |
| IGLV1-51 | 29 |
| RAB7A | 23 |
| TUBB1 | 22 |
| FABP5 | 17 |
| A1BG | 16 |
| IL6R | 10 |
| PFKL | 6 |
| LCN2 | 5 |
| YWHAZ | 3 |
| FLG2 | 0 |
| TALDO1 | -2 |
| PA2G4 | -3 |
| PKM | -6 |
| TTR | -7 |
| CTSF | -9 |
| IGHV2-70 | -10 |
| VCL | -11 |
| C1R | -16 |
| PDIA3 | -21 |
| C1QB | -24 |
| FN1 | -25 |
| VTN | -26 |
| BPIFB1 | -27 |
| LILRA2 | -28 |
| FTL | -34 |
| ALDOC | -38 |
| F13A1 | -39 |
| CD93 | -41 |
| HSPA5 | -45 |
| IGHV3-30 | -46 |
| FLNA | -51 |
| ACTR3 | -54 |
| HSPA1A | -55 |
| TUBA4A | -57 |
| VASP | -60 |
| SELL | -64 |
| CLU | -65 |
| FUCA1 | -68 |
| SNAP23 | -71 |
| ARPC3 | -72 |
| DYNC1H1 | -73 |
| HSP90B1 | -77 |
| PGLYRP2 | -79 |
| CPN2 | -81 |
| VCP | -83 |
| IGHG2 | -85 |
| PYGL | -87 |
| IGHV2-5 | -94 |
| MYH9 | -97 |
| PGAM1 | -100 |
| C3 | -102 |
| ACTB | -109 |
| HSP90AA1 | -123 |
| HLA-C | -127 |
| IGHM | -131 |
| PVR | -133 |
| GDI2 | -139 |
| PSMA1 | -142 |
| IGKV1-17 | -143 |
| VNN1 | -146 |
| FKBP1A | -149 |
| SLPI | -153 |
| PPIA | -155 |
| CAP1 | -158 |
| FTH1 | -159 |
| IGHV3-9 | -165 |
| IGLV2-18 | -167 |
| CALM1 | -169 |
| ARPC2 | -171 |
| F2 | -177 |
| ERAP2 | -180 |
| IGHG4 | -185 |
| IGHV1-2 | -186 |
| IGHD | -188 |
| S100A7 | -190 |
| BIN2 | -192 |
| MSN | -203 |
| PSMA6 | -205 |
| STOM | -208 |
| IGKV1-16 | -209 |
| PYGB | -211 |
| GSN | -215 |
| SERPINB1 | -216 |
| CCT2 | -221 |
| HEXB | -224 |
| TGFB1 | -225 |
| ARPC1B | -228 |
| BCAP31 | -233 |
| APOB | -240 |
| FCER1G | -242 |
| IGLC2 | -244 |
| COTL1 | -253 |
| PPBP | -255 |
| ITGB1 | -258 |
| IGKV1-5 | -260 |
| IGKV3D-20 | -262 |
| CHGA | -263 |
| PSMB2 | -265 |
| GSTP1 | -266 |
| LCP1 | -267 |
| SRC | -270 |
| HSP90AB1 | -271 |
| EEF1A1 | -273 |
| GSTO1 | -281 |
| IGLV3-16 | -282 |
| IGKC | -284 |
| IGLV4-60 | -285 |
| ANO6 | -287 |
| IGLV2-23 | -290 |
| ACLY | -291 |
| CALML5 | -292 |
| UBE2O | -293 |
| ITLN1 | -302 |
| PECAM1 | -307 |
| AGA | -308 |
| CNN2 | -312 |
| CD99 | -315 |
| RAB14 | -316 |
| C4A | -319 |
| CYB5R3 | -322 |
| YWHAG | -325 |
| PSMB3 | -331 |
| IGKV3-20 | -333 |
| TPP2 | -334 |
| TIMP1 | -336 |
| IGHG1 | -337 |
| ARG1 | -343 |
| ANXA2 | -345 |
| IGKV1D-16 | -348 |
| CANX | -352 |
| HLA-B | -358 |
| TUBA8 | -364 |
| PSMB7 | -368 |
| FYN | -369 |
| S100A8 | -370 |
| CCT8 | -379 |
| S100A9 | -380 |
| ADAM10 | -387 |
| CAPZA1 | -390 |
| CTSB | -391 |
| HLA-A | -392 |
| RNASE2 | -400 |
| RASGRP2 | -402 |
| ARPC4 | -403 |
| set | Cell-extracellular matrix interactions |
| setSize | 9 |
| pANOVA | 0.0453 |
| s.dist | -0.387 |
| p.adjustANOVA | 0.757 |
| GeneID | Gene Rank |
|---|---|
| ITGB1 | -258 |
| RSU1 | -245 |
| PARVB | -236 |
| LIMS1 | -174 |
| ACTB | -109 |
| ACTN1 | -96 |
| VASP | -60 |
| FLNA | -51 |
| ILK | 79 |
| GeneID | Gene Rank |
|---|---|
| ITGB1 | -258 |
| RSU1 | -245 |
| PARVB | -236 |
| LIMS1 | -174 |
| ACTB | -109 |
| ACTN1 | -96 |
| VASP | -60 |
| FLNA | -51 |
| ILK | 79 |
| set | EPHB-mediated forward signaling |
| setSize | 12 |
| pANOVA | 0.0465 |
| s.dist | -0.334 |
| p.adjustANOVA | 0.757 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| FYN | -369 |
| SRC | -270 |
| ROCK2 | -256 |
| ARPC1B | -228 |
| ARPC2 | -171 |
| ACTB | -109 |
| ARPC3 | -72 |
| ACTR3 | -54 |
| ACTR2 | 107 |
| ARPC5 | 167 |
| CFL1 | 416 |
| GeneID | Gene Rank |
|---|---|
| ARPC4 | -403 |
| FYN | -369 |
| SRC | -270 |
| ROCK2 | -256 |
| ARPC1B | -228 |
| ARPC2 | -171 |
| ACTB | -109 |
| ARPC3 | -72 |
| ACTR3 | -54 |
| ACTR2 | 107 |
| ARPC5 | 167 |
| CFL1 | 416 |
| set | Complement cascade |
| setSize | 91 |
| pANOVA | 0.0557 |
| s.dist | 0.122 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| CFHR2 | 489 |
| ELANE | 475 |
| IGLV7-43 | 463 |
| CFHR4 | 454 |
| IGHV1-46 | 446 |
| CFHR1 | 439 |
| IGLV3-19 | 427 |
| IGLV2-8 | 406 |
| IGLV4-69 | 385 |
| IGHV3-48 | 371 |
| COLEC10 | 364 |
| CPN1 | 359 |
| MASP2 | 356 |
| CFH | 340 |
| IGLV8-61 | 336 |
| C4BPA | 318 |
| C2 | 317 |
| CFD | 315 |
| IGLV1-44 | 308 |
| IGLV1-40 | 300 |
| GeneID | Gene Rank |
|---|---|
| CFHR2 | 489 |
| ELANE | 475 |
| IGLV7-43 | 463 |
| CFHR4 | 454 |
| IGHV1-46 | 446 |
| CFHR1 | 439 |
| IGLV3-19 | 427 |
| IGLV2-8 | 406 |
| IGLV4-69 | 385 |
| IGHV3-48 | 371 |
| COLEC10 | 364 |
| CPN1 | 359 |
| MASP2 | 356 |
| CFH | 340 |
| IGLV8-61 | 336 |
| C4BPA | 318 |
| C2 | 317 |
| CFD | 315 |
| IGLV1-44 | 308 |
| IGLV1-40 | 300 |
| C4BPB | 292 |
| IGHV3-13 | 285 |
| CPB2 | 282 |
| CFB | 277 |
| C9 | 244 |
| COLEC11 | 215 |
| C1QC | 211 |
| IGHV3-7 | 205 |
| CRP | 201 |
| MASP1 | 199 |
| CFHR5 | 197 |
| MBL2 | 191 |
| C6 | 190 |
| IGHV3-23 | 186 |
| SERPING1 | 184 |
| C1QA | 161 |
| IGHV4-34 | 146 |
| FCN1 | 145 |
| IGLV6-57 | 144 |
| FCN3 | 136 |
| IGLV4-3 | 134 |
| IGHV1-69 | 131 |
| C8G | 127 |
| IGLV2-11 | 122 |
| C4B | 117 |
| IGLV2-14 | 116 |
| IGKV3-11 | 113 |
| IGKV1D-33 | 111 |
| CFP | 109 |
| C7 | 88 |
| IGLC7 | 81 |
| IGKV4-1 | 80 |
| C8B | 78 |
| CFI | 75 |
| IGHG3 | 65 |
| PROS1 | 63 |
| C1S | 56 |
| IGLV1-47 | 53 |
| C5 | 48 |
| FCN2 | 45 |
| C8A | 44 |
| IGLV1-36 | 40 |
| IGLV1-51 | 29 |
| IGHV2-70 | -10 |
| C1R | -16 |
| C1QB | -24 |
| VTN | -26 |
| IGHV3-30 | -46 |
| CLU | -65 |
| CPN2 | -81 |
| IGHG2 | -85 |
| IGHV2-5 | -94 |
| C3 | -102 |
| IGKV1-17 | -143 |
| IGHV3-9 | -165 |
| IGLV2-18 | -167 |
| F2 | -177 |
| IGHG4 | -185 |
| IGHV1-2 | -186 |
| IGKV1-16 | -209 |
| IGLC2 | -244 |
| IGKV1-5 | -260 |
| IGKV3D-20 | -262 |
| IGLV3-16 | -282 |
| IGKC | -284 |
| IGLV4-60 | -285 |
| IGLV2-23 | -290 |
| C4A | -319 |
| IGKV3-20 | -333 |
| IGHG1 | -337 |
| IGKV1D-16 | -348 |
| set | Smooth Muscle Contraction |
| setSize | 12 |
| pANOVA | 0.0584 |
| s.dist | -0.318 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| TPM3 | -394 |
| ANXA2 | -345 |
| MYL9 | -277 |
| TPM4 | -178 |
| CALM1 | -169 |
| MYL6 | -156 |
| TLN1 | -86 |
| CALD1 | -18 |
| VCL | -11 |
| MYL12B | -4 |
| ANXA1 | 46 |
| TPM1 | 438 |
| GeneID | Gene Rank |
|---|---|
| TPM3 | -394 |
| ANXA2 | -345 |
| MYL9 | -277 |
| TPM4 | -178 |
| CALM1 | -169 |
| MYL6 | -156 |
| TLN1 | -86 |
| CALD1 | -18 |
| VCL | -11 |
| MYL12B | -4 |
| ANXA1 | 46 |
| TPM1 | 438 |
| set | Cell surface interactions at the vascular wall |
| setSize | 75 |
| pANOVA | 0.0659 |
| s.dist | -0.128 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| ITGA6 | -401 |
| FYN | -369 |
| MERTK | -367 |
| IGKV1D-16 | -348 |
| IGKV3-20 | -333 |
| CD99 | -315 |
| PECAM1 | -307 |
| IGLV2-23 | -290 |
| IGLV4-60 | -285 |
| IGKC | -284 |
| IGLV3-16 | -282 |
| SRC | -270 |
| IGKV3D-20 | -262 |
| IGKV1-5 | -260 |
| ITGB1 | -258 |
| PF4 | -252 |
| IGLC2 | -244 |
| FCER1G | -242 |
| APOB | -240 |
| TGFB1 | -225 |
| GeneID | Gene Rank |
|---|---|
| ITGA6 | -401 |
| FYN | -369 |
| MERTK | -367 |
| IGKV1D-16 | -348 |
| IGKV3-20 | -333 |
| CD99 | -315 |
| PECAM1 | -307 |
| IGLV2-23 | -290 |
| IGLV4-60 | -285 |
| IGKC | -284 |
| IGLV3-16 | -282 |
| SRC | -270 |
| IGKV3D-20 | -262 |
| IGKV1-5 | -260 |
| ITGB1 | -258 |
| PF4 | -252 |
| IGLC2 | -244 |
| FCER1G | -242 |
| APOB | -240 |
| TGFB1 | -225 |
| IGKV1-16 | -209 |
| SELP | -193 |
| IGHV1-2 | -186 |
| F2 | -177 |
| IGLV2-18 | -167 |
| IGHV3-9 | -165 |
| PPIA | -155 |
| IGHA2 | -154 |
| IGKV1-17 | -143 |
| IGHM | -131 |
| JCHAIN | -108 |
| IGHA1 | -101 |
| ITGB3 | -98 |
| IGHV2-5 | -94 |
| SELL | -64 |
| IGHV3-30 | -46 |
| FN1 | -25 |
| F11R | -22 |
| IGHV2-70 | -10 |
| PROC | 15 |
| IGLL1 | 18 |
| IGLV1-51 | 29 |
| IGLV1-36 | 40 |
| ITGB2 | 49 |
| IGLV1-47 | 53 |
| SIRPA | 54 |
| PROS1 | 63 |
| IGKV4-1 | 80 |
| IGLC7 | 81 |
| SLC3A2 | 98 |
| IGKV1D-33 | 111 |
| IGKV3-11 | 113 |
| IGLV2-14 | 116 |
| IGLV2-11 | 122 |
| IGHV1-69 | 131 |
| IGLV4-3 | 134 |
| IGLV6-57 | 144 |
| IGHV4-34 | 146 |
| IGHV3-23 | 186 |
| IGHV3-7 | 205 |
| L1CAM | 271 |
| IGHV3-13 | 285 |
| IGLV1-40 | 300 |
| IGLV1-44 | 308 |
| PF4V1 | 309 |
| IGLV8-61 | 336 |
| GRB2 | 368 |
| IGHV3-48 | 371 |
| IGLV4-69 | 385 |
| CD44 | 398 |
| IGLV2-8 | 406 |
| IGLV3-19 | 427 |
| IGHV1-46 | 446 |
| CD84 | 452 |
| IGLV7-43 | 463 |
| set | RHO GTPase cycle |
| setSize | 38 |
| pANOVA | 0.0666 |
| s.dist | -0.176 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| TPM3 | -394 |
| CCT6A | -339 |
| FLOT2 | -326 |
| ARHGDIB | -305 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| BCAP31 | -233 |
| CCT2 | -221 |
| STOM | -208 |
| TPM4 | -178 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| BASP1 | -103 |
| ACTN1 | -96 |
| VCP | -83 |
| PLXNB1 | -80 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| TPM3 | -394 |
| CCT6A | -339 |
| FLOT2 | -326 |
| ARHGDIB | -305 |
| STIP1 | -275 |
| HSP90AB1 | -271 |
| SRC | -270 |
| ITGB1 | -258 |
| ROCK2 | -256 |
| BCAP31 | -233 |
| CCT2 | -221 |
| STOM | -208 |
| TPM4 | -178 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| BASP1 | -103 |
| ACTN1 | -96 |
| VCP | -83 |
| PLXNB1 | -80 |
| SNAP23 | -71 |
| AKAP12 | -70 |
| TFRC | -53 |
| DSG2 | -49 |
| ACTC1 | 4 |
| RAB7A | 23 |
| MCAM | 37 |
| HSPE1 | 152 |
| CLTC | 178 |
| JUP | 302 |
| DSG1 | 303 |
| RHOC | 314 |
| DSP | 321 |
| TXNL1 | 367 |
| GRB2 | 368 |
| IQGAP2 | 383 |
| ARHGAP1 | 397 |
| DIAPH1 | 460 |
| set | ECM proteoglycans |
| setSize | 23 |
| pANOVA | 0.0674 |
| s.dist | -0.223 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| ITGA2 | -361 |
| LAMC1 | -356 |
| DAG1 | -324 |
| ITGB1 | -258 |
| TGFB1 | -225 |
| SPARC | -170 |
| TNC | -140 |
| ITGB3 | -98 |
| TNXB | -76 |
| COL6A1 | -59 |
| ITGA2B | -52 |
| VTN | -26 |
| FN1 | -25 |
| COMP | -23 |
| HSPG2 | -15 |
| LUM | 8 |
| LAMB1 | 28 |
| LAMA2 | 34 |
| NCAM1 | 43 |
| APP | 68 |
| GeneID | Gene Rank |
|---|---|
| ITGA2 | -361 |
| LAMC1 | -356 |
| DAG1 | -324 |
| ITGB1 | -258 |
| TGFB1 | -225 |
| SPARC | -170 |
| TNC | -140 |
| ITGB3 | -98 |
| TNXB | -76 |
| COL6A1 | -59 |
| ITGA2B | -52 |
| VTN | -26 |
| FN1 | -25 |
| COMP | -23 |
| HSPG2 | -15 |
| LUM | 8 |
| LAMB1 | 28 |
| LAMA2 | 34 |
| NCAM1 | 43 |
| APP | 68 |
| COL6A3 | 216 |
| SERPINE1 | 220 |
| COL4A1 | 377 |
| set | RHOH GTPase cycle |
| setSize | 8 |
| pANOVA | 0.0677 |
| s.dist | -0.375 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| ARHGDIB | -305 |
| ROCK2 | -256 |
| STOM | -208 |
| VCP | -83 |
| TFRC | -53 |
| RAB7A | 23 |
| JUP | 302 |
| GeneID | Gene Rank |
|---|---|
| DBN1 | -399 |
| ARHGDIB | -305 |
| ROCK2 | -256 |
| STOM | -208 |
| VCP | -83 |
| TFRC | -53 |
| RAB7A | 23 |
| JUP | 302 |
| set | Response of endothelial cells to shear stress |
| setSize | 16 |
| pANOVA | 0.0707 |
| s.dist | -0.263 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| ANXA2 | -345 |
| PECAM1 | -307 |
| FLT4 | -261 |
| ITGB1 | -258 |
| GNB2 | -223 |
| CALM1 | -169 |
| CAPNS1 | -137 |
| ITGB3 | -98 |
| TLN1 | -86 |
| FN1 | -25 |
| VCL | -11 |
| CDH5 | 27 |
| PRKAR1A | 335 |
| GNAQ | 366 |
| GNB1 | 418 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| ANXA2 | -345 |
| PECAM1 | -307 |
| FLT4 | -261 |
| ITGB1 | -258 |
| GNB2 | -223 |
| CALM1 | -169 |
| CAPNS1 | -137 |
| ITGB3 | -98 |
| TLN1 | -86 |
| FN1 | -25 |
| VCL | -11 |
| CDH5 | 27 |
| PRKAR1A | 335 |
| GNAQ | 366 |
| GNB1 | 418 |
| set | Metabolism of Angiotensinogen to Angiotensins |
| setSize | 7 |
| pANOVA | 0.0723 |
| s.dist | 0.394 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| CTSZ | 481 |
| AGT | 346 |
| CPB2 | 282 |
| CTSD | 252 |
| ACE | 166 |
| ANPEP | 140 |
| CES1 | -112 |
| GeneID | Gene Rank |
|---|---|
| CTSZ | 481 |
| AGT | 346 |
| CPB2 | 282 |
| CTSD | 252 |
| ACE | 166 |
| ANPEP | 140 |
| CES1 | -112 |
| set | RHO GTPases activate PAKs |
| setSize | 7 |
| pANOVA | 0.0756 |
| s.dist | -0.389 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| MYL9 | -277 |
| CALM1 | -169 |
| MYL6 | -156 |
| CTTN | -150 |
| MYH9 | -97 |
| FLNA | -51 |
| MYL12B | -4 |
| GeneID | Gene Rank |
|---|---|
| MYL9 | -277 |
| CALM1 | -169 |
| MYL6 | -156 |
| CTTN | -150 |
| MYH9 | -97 |
| FLNA | -51 |
| MYL12B | -4 |
| set | Interaction between L1 and Ankyrins |
| setSize | 5 |
| pANOVA | 0.0762 |
| s.dist | 0.459 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| SPTB | 391 |
| SPTA1 | 374 |
| ANK1 | 333 |
| L1CAM | 271 |
| ACTB | -109 |
| GeneID | Gene Rank |
|---|---|
| SPTB | 391 |
| SPTA1 | 374 |
| ANK1 | 333 |
| L1CAM | 271 |
| ACTB | -109 |
| set | Signaling by VEGF |
| setSize | 13 |
| pANOVA | 0.0772 |
| s.dist | -0.285 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| SRC | -270 |
| FLT4 | -261 |
| ROCK2 | -256 |
| CALM1 | -169 |
| HSPB1 | -168 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| ITGB3 | -98 |
| CDH5 | 27 |
| NRP2 | 179 |
| NRP1 | 255 |
| JUP | 302 |
| GeneID | Gene Rank |
|---|---|
| FYN | -369 |
| SRC | -270 |
| FLT4 | -261 |
| ROCK2 | -256 |
| CALM1 | -169 |
| HSPB1 | -168 |
| HSP90AA1 | -123 |
| ACTB | -109 |
| ITGB3 | -98 |
| CDH5 | 27 |
| NRP2 | 179 |
| NRP1 | 255 |
| JUP | 302 |
| set | Asparagine N-linked glycosylation |
| setSize | 41 |
| pANOVA | 0.0799 |
| s.dist | 0.162 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| CTSZ | 481 |
| TUBA1C | 478 |
| B4GALT1 | 468 |
| MLEC | 466 |
| ACTR1A | 461 |
| UGGT1 | 435 |
| ARF4 | 433 |
| ASGR2 | 421 |
| ST6GALNAC1 | 407 |
| MAN2A1 | 395 |
| SPTB | 391 |
| SPTA1 | 374 |
| PRKCSH | 355 |
| ANK1 | 333 |
| ST6GAL1 | 325 |
| RPS27A | 305 |
| GANAB | 270 |
| TUBB4B | 230 |
| TFG | 214 |
| SERPINA1 | 158 |
| GeneID | Gene Rank |
|---|---|
| CTSZ | 481 |
| TUBA1C | 478 |
| B4GALT1 | 468 |
| MLEC | 466 |
| ACTR1A | 461 |
| UGGT1 | 435 |
| ARF4 | 433 |
| ASGR2 | 421 |
| ST6GALNAC1 | 407 |
| MAN2A1 | 395 |
| SPTB | 391 |
| SPTA1 | 374 |
| PRKCSH | 355 |
| ANK1 | 333 |
| ST6GAL1 | 325 |
| RPS27A | 305 |
| GANAB | 270 |
| TUBB4B | 230 |
| TFG | 214 |
| SERPINA1 | 158 |
| MAN1A1 | 125 |
| CTSC | 72 |
| CALR | 64 |
| LMAN2 | 59 |
| TUBB1 | 22 |
| RAB1B | 14 |
| PDIA3 | -21 |
| TUBA4A | -57 |
| FUCA1 | -68 |
| DYNC1H1 | -73 |
| VCP | -83 |
| F8 | -144 |
| TMED7 | -173 |
| F5 | -220 |
| HK1 | -243 |
| UMOD | -274 |
| ARF3 | -279 |
| RAB1A | -289 |
| CANX | -352 |
| TUBA8 | -364 |
| CAPZA1 | -390 |
| set | Lectin pathway of complement activation |
| setSize | 8 |
| pANOVA | 0.08 |
| s.dist | 0.359 |
| p.adjustANOVA | 0.876 |
| GeneID | Gene Rank |
|---|---|
| COLEC10 | 364 |
| MASP2 | 356 |
| COLEC11 | 215 |
| MASP1 | 199 |
| MBL2 | 191 |
| FCN1 | 145 |
| FCN3 | 136 |
| FCN2 | 45 |
| GeneID | Gene Rank |
|---|---|
| COLEC10 | 364 |
| MASP2 | 356 |
| COLEC11 | 215 |
| MASP1 | 199 |
| MBL2 | 191 |
| FCN1 | 145 |
| FCN3 | 136 |
| FCN2 | 45 |
Only used for one-dimensional analysis.
Here, the network diagram is used to depict the similarity between some of the top ranked gene sets. It makes separate charts for up and downregulated sets. It works best when prioritisation is done by effect size during the mitch_calc() step. By default, we only show the top 20 genes, but you can use the networkplot() command yourself with other options. See ?networkplot for more detail. There is an element of stochasticity with regard to the network projection, so if you see a lot of overlapping labels or labels getting cut off, you could repeat the chart generation until you get a nice layout. See ?networkplot for more detail.
Below the network diagrams, you will see lists of genes that make up the up and downregulated sets respectively. For upregulated genes the score needs to be >2 and for downregulated genes it needs to be < -2. This is to remove genes that have uninteresting differential expression and do not contribute enrichment.
if (d==1) {
networkplot(eres=res,FDR=0.05,n_sets=20)
network_genes(eres=res,FDR=0.05,n_sets=20)
} else {
message("Network charts only generated in one-dimensional analysis.")
}
## Can't plot upregulated sets. Fewer than 5 found.
## Can't plot downregulated sets. Fewer than 5 found.
## No significant upregulated sets to show.
## No significant upregulated sets to show.
## [[1]]
## NULL
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.6.0 (2026-04-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 24.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.26.so; LAPACK version 3.12.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] PLSDAbatch_2.0.0 kableExtra_1.4.0 gtools_3.9.5
## [4] beeswarm_0.4.0 eulerr_7.1.0 msigdbr_26.1.0
## [7] mitch_1.24.0 knitr_1.51 ReactomePA_1.56.0
## [10] umap_0.2.10.0 org.Hs.eg.db_3.23.1 AnnotationDbi_1.74.0
## [13] IRanges_2.46.0 S4Vectors_0.50.1 Biobase_2.72.0
## [16] BiocGenerics_0.58.1 generics_0.1.4 clusterProfiler_4.20.0
## [19] pheatmap_1.0.13 limma_3.68.2 janitor_2.2.1
## [22] lubridate_1.9.5 forcats_1.0.1 stringr_1.6.0
## [25] purrr_1.2.2 readr_2.2.0 tidyr_1.3.2
## [28] tibble_3.3.1 ggplot2_4.0.3 tidyverse_2.0.0
## [31] dplyr_1.2.1 BiocManager_1.30.27
##
## loaded via a namespace (and not attached):
## [1] matrixStats_1.5.0 fs_2.1.0 bitops_1.0-9
## [4] enrichplot_1.32.0 insight_1.5.0 httr_1.4.8
## [7] RColorBrewer_1.1-3 numDeriv_2016.8-1.1 tools_4.6.0
## [10] backports_1.5.1 utf8_1.2.6 R6_2.6.1
## [13] lazyeval_0.2.3 withr_3.0.2 graphite_1.58.0
## [16] GGally_2.4.0 gridExtra_2.3 performance_0.16.0
## [19] cli_3.6.6 textshaping_1.0.5 network_1.20.0
## [22] scatterpie_0.2.6 labeling_0.4.3 sass_0.4.10
## [25] S7_0.2.2 askpass_1.2.1 systemfonts_1.3.2
## [28] yulab.utils_0.2.4 gson_0.1.0 DOSE_4.6.0
## [31] svglite_2.2.2 dichromat_2.0-0.1 rstudioapi_0.18.0
## [34] RSQLite_3.52.0 gridGraphics_0.5-1 vroom_1.7.1
## [37] car_3.1-5 GO.db_3.23.1 Matrix_1.7-5
## [40] abind_1.4-8 lifecycle_1.0.5 yaml_2.3.12
## [43] snakecase_0.11.1 carData_3.0-6 gplots_3.3.0
## [46] qvalue_2.44.0 grid_4.6.0 blob_1.3.0
## [49] promises_1.5.0 crayon_1.5.3 ggtangle_0.1.2
## [52] lattice_0.22-9 echarts4r_0.5.0 KEGGREST_1.52.0
## [55] pillar_1.11.1 boot_1.3-32 corpcor_1.6.10
## [58] codetools_0.2-20 mixOmics_6.36.0 glue_1.8.1
## [61] ggiraph_0.9.6 ggfun_0.2.0 fontLiberation_0.1.0
## [64] vctrs_0.7.3 png_0.1-9 treeio_1.36.1
## [67] Rdpack_2.6.6 gtable_0.3.6 assertthat_0.2.1
## [70] cachem_1.1.0 xfun_0.57 rbibutils_2.4.1
## [73] mime_0.13 tidygraph_1.3.1 Seqinfo_1.2.0
## [76] reformulas_0.4.4 coda_0.19-4.1 aisdk_1.1.0
## [79] statmod_1.5.2 nlme_3.1-169 ggtree_4.2.0
## [82] bit64_4.8.0 fontquiver_0.2.1 bslib_0.11.0
## [85] KernSmooth_2.23-26 otel_0.2.0 DBI_1.3.0
## [88] tidyselect_1.2.1 processx_3.9.0 bit_4.6.0
## [91] compiler_4.6.0 curl_7.1.0 httr2_1.2.2
## [94] graph_1.90.0 xml2_1.5.2 fontBitstreamVera_0.1.1
## [97] scales_1.4.0 caTools_1.18.3 callr_3.7.6
## [100] rappdirs_0.3.4 digest_0.6.39 minqa_1.2.8
## [103] rmarkdown_2.31 XVector_0.52.0 htmltools_0.5.9
## [106] pkgconfig_2.0.3 lme4_2.0-1 fastmap_1.2.0
## [109] rlang_1.2.0 htmlwidgets_1.6.4 shiny_1.13.0
## [112] farver_2.1.2 jquerylib_0.1.4 jsonlite_2.0.0
## [115] BiocParallel_1.46.0 statnet.common_4.13.0 GOSemSim_2.38.0
## [118] magrittr_2.0.5 Formula_1.2-5 ggplotify_0.1.3
## [121] patchwork_1.3.2 Rcpp_1.1.1-1.1 ape_5.8-1
## [124] babelgene_22.9 ggnewscale_0.5.2 viridis_0.6.5
## [127] gdtools_0.5.0 reticulate_1.46.0 stringi_1.8.7
## [130] ggraph_2.2.2 MASS_7.3-65 plyr_1.8.9
## [133] ggstats_0.13.0 parallel_4.6.0 ggrepel_0.9.8
## [136] Biostrings_2.80.0 graphlayouts_1.2.3 splines_4.6.0
## [139] hms_1.1.4 polylabelr_1.0.0 ps_1.9.3
## [142] igraph_2.3.1 ggpubr_0.6.3 ggsignif_0.6.4
## [145] enrichit_0.1.4 reshape2_1.4.5 evaluate_1.0.5
## [148] nloptr_2.2.1 tzdb_0.5.0 tweenr_2.0.3
## [151] httpuv_1.6.17 openssl_2.4.1 polyclip_1.10-7
## [154] ggforce_0.5.0 broom_1.0.13 xtable_1.8-8
## [157] reactome.db_1.96.0 RSpectra_0.16-2 tidytree_0.4.7
## [160] tidydr_0.0.6 rstatix_0.7.3 later_1.4.8
## [163] viridisLite_0.4.3 rARPACK_0.11-0 lmerTest_3.2-1
## [166] aplot_0.2.9 ellipse_0.5.0 memoise_2.0.1
## [169] cluster_2.1.8.2 timechange_0.4.0
END of report